Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionaspartic-type endopeptidase activity

ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-18 ERVK-19 ERVK-25 ERVK-24 ERVK-8

3.74e-10372379GO:0004190
GeneOntologyMolecularFunctionaspartic-type peptidase activity

ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-18 ERVK-19 ERVK-25 ERVK-24 ERVK-8

4.85e-10382379GO:0070001
GeneOntologyMolecularFunction1-phosphatidylinositol-4-phosphate 3-kinase activity

PIK3C2A PIK3C2G PIK3CG

5.58e-0572373GO:0035005
GeneOntologyMolecularFunctioncadherin binding

CTNNAL1 SPTBN1 BMPR2 CDH20 PKM TJP2 DLG1 NOTCH3 CDH24 MACF1 CDH7 PLIN3 CDH18 LRRFIP1

5.75e-0533923714GO:0045296
GeneOntologyMolecularFunctioncalcium ion binding

PKD1L2 LRP1B FAT1 CDH20 ASTN2 NOTCH3 FAT4 DSG2 MAN1C1 TTYH2 PLCD4 TGM2 CDH24 THBS3 SLIT3 LRP1 MACF1 UNC13C LTBP3 PCDH7 CDH7 CDH18

9.09e-0574923722GO:0005509
GeneOntologyMolecularFunctionbeta-catenin binding

KANK1 CDH20 AMER3 TBL1XR1 CDH24 TREM2 CDH7 CDH18

9.39e-051202378GO:0008013
GeneOntologyMolecularFunctiontransferase activity, transferring phosphorus-containing groups

ERVK-6 ILK ERVK-7 ITPK1 NEK4 MYO3A BMPR2 COQ8A PIK3C2A PIK3C2G PIK3CG PKM TJP2 DLG1 PIGO WNK3 KALRN NTRK2 POLH SCYL3 STK32C RPAP1 ERVK-8 CHEK2 WEE2

1.40e-0493823725GO:0016772
GeneOntologyMolecularFunctiondinucleotide repeat insertion binding

MSH2 MSH3

1.40e-0422372GO:0032181
GeneOntologyMolecularFunctionendopeptidase activity

ERVK-6 HGFAC ADAM23 C1RL ERVK-7 ERVK-21 ERVK-9 ADAMTS9 ERVK-18 ERVK-19 ERVK-25 UQCRC2 ERVK-24 PIGK ERVK-8

2.05e-0443023715GO:0004175
GeneOntologyMolecularFunctionRNA-DNA hybrid ribonuclease activity

ERVK-6 ERVK-7 ERVK-8

2.54e-04112373GO:0004523
GeneOntologyMolecularFunction1-phosphatidylinositol-3-kinase activity

PIK3C2A PIK3C2G PIK3CG

2.54e-04112373GO:0016303
GeneOntologyMolecularFunctioncell adhesion molecule binding

CTNNAL1 ILK ADAM23 SPTBN1 ITGA4 BMPR2 CDH20 PKM TJP2 DLG1 NOTCH3 DSG2 CDH24 MACF1 CDH7 PLIN3 CDH18 LRRFIP1

3.05e-0459923718GO:0050839
GeneOntologyMolecularFunctionsingle guanine insertion binding

MSH2 MSH3

4.18e-0432372GO:0032142
GeneOntologyMolecularFunctiondinucleotide insertion or deletion binding

MSH2 MSH3

4.18e-0432372GO:0032139
GeneOntologyMolecularFunctionRNA-directed DNA polymerase activity

ERVK-6 ERVK-7 ERVK-8

5.46e-04142373GO:0003964
GeneOntologyMolecularFunctionmicrotubule minus-end binding

TUBGCP2 TUBGCP4 MACF1

6.76e-04152373GO:0051011
GeneOntologyMolecularFunctionbrain-derived neurotrophic factor binding

A2M NTRK2

8.29e-0442372GO:0048403
GeneOntologyMolecularFunctionguanine/thymine mispair binding

MSH2 MSH3

8.29e-0442372GO:0032137
GeneOntologyMolecularFunctionsingle base insertion or deletion binding

MSH2 MSH3

8.29e-0442372GO:0032138
GeneOntologyMolecularFunctionpeptidase activity

ERVK-6 HGFAC ADAM23 C1RL ERVK-7 ERVK-21 ERVK-9 ADAMTS9 AGA ERVK-18 ERVK-19 ERVK-25 UQCRC2 ERVK-24 PIGK TGM2 PRCP ERVK-8

8.52e-0465423718GO:0008233
GeneOntologyMolecularFunctionDNA polymerase activity

ERVK-6 ERVK-7 POLH ERVK-8

1.04e-03382374GO:0034061
GeneOntologyMolecularFunctioncatalytic activity, acting on DNA

ERVK-6 ERCC6 ERVK-7 POLH CHD9 MSH2 MSH3 TOP6BL LIG4 ERVK-8

1.20e-0326223710GO:0140097
GeneOntologyBiologicalProcessDNA recombination

ERVK-6 ERCC6 ERVK-7 TNFSF4 BRD8 TOPBP1 MSH2 MSH3 TOP6BL TEX15 MORC2 CEP63 LIG4 RIF1 SETD2 ERVK-8 IL7R

1.28e-0636823617GO:0006310
GeneOntologyBiologicalProcessDNA repair

ERVK-6 CDKN2D ERCC6 ERVK-7 BRD8 ABRAXAS1 BOD1L1 TAF2 PML POLH TOPBP1 MSH2 MSH3 TEX15 MORC2 LIG4 RIF1 SETD2 WDHD1 ERVK-8 CHEK2

1.92e-0564823621GO:0006281
GeneOntologyBiologicalProcesscell-cell fusion

ERVK-6 ERVK-21 ERVK-9 DCSTAMP ERVK-19 ERVK-8 TREM2

5.43e-05852367GO:0140253
GeneOntologyBiologicalProcesssyncytium formation by plasma membrane fusion

ERVK-6 ERVK-21 ERVK-9 DCSTAMP ERVK-19 ERVK-8 TREM2

5.43e-05852367GO:0000768
GeneOntologyBiologicalProcessregulation of DNA recombination

ERCC6 TNFSF4 BRD8 MSH2 MSH3 TEX15 RIF1 SETD2 IL7R

5.92e-051502369GO:0000018
GeneOntologyBiologicalProcesssyncytium formation

ERVK-6 ERVK-21 ERVK-9 DCSTAMP ERVK-19 ERVK-8 TREM2

7.30e-05892367GO:0006949
GeneOntologyCellularComponentapical plasma membrane

ACY3 SLC39A8 ITPK1 BMPR2 FAT1 CFAP126 DLG1 SLC5A12 SLC38A3 CNTFR DSG2 SLC12A1 SLC26A7 CD34 CSPG4 SLC39A14 ATP12A PATJ

1.23e-0548723718GO:0016324
GeneOntologyCellularComponentapical part of cell

ACY3 SLC39A8 ITPK1 BMPR2 FAT1 CFAP126 DLG1 SLC5A12 SLC38A3 CNTFR FAT4 DSG2 SLC12A1 SLC26A7 CD34 CSPG4 LRP1 SLC39A14 ATP12A PATJ

1.49e-0559223720GO:0045177
GeneOntologyCellularComponentadherens junction

KLHL24 BMPR2 CDH20 TJP2 DLG1 WNK3 JCAD CDH24 LLGL2 CDH7 CDH18

3.20e-0521223711GO:0005912
GeneOntologyCellularComponentMutSbeta complex

MSH2 MSH3

1.28e-0422372GO:0032302
GeneOntologyCellularComponentcell-cell junction

KLHL24 ILK ITGA4 BMPR2 FAT1 CDH20 TJP2 DLG1 WNK3 JCAD THEMIS DSG2 CNTNAP1 CDH24 LLGL2 PATJ CDH7 CDH18

1.49e-0459123718GO:0005911
GeneOntologyCellularComponentextracellular matrix

A2M SERPINA3 IL16 COL6A5 PLXNB2 FREM1 ANOS1 FCGBP ADAMTS9 PKM DLG1 SCARA3 COL6A3 CPN2 TGM2 THBS3 LINGO1 CSPG4 LTBP3

1.86e-0465623719GO:0031012
GeneOntologyCellularComponentexternal encapsulating structure

A2M SERPINA3 IL16 COL6A5 PLXNB2 FREM1 ANOS1 FCGBP ADAMTS9 PKM DLG1 SCARA3 COL6A3 CPN2 TGM2 THBS3 LINGO1 CSPG4 LTBP3

1.94e-0465823719GO:0030312
GeneOntologyCellularComponentextrinsic component of membrane

FBXO2 CDH20 PIK3C2A PIK3C2G PIK3CG CNTFR KALRN CDH24 CDH7 CDH18

3.10e-0423023710GO:0019898
GeneOntologyCellularComponentcollagen-containing extracellular matrix

A2M SERPINA3 IL16 COL6A5 PLXNB2 FREM1 ADAMTS9 PKM DLG1 SCARA3 COL6A3 CPN2 TGM2 THBS3 CSPG4 LTBP3

3.83e-0453023716GO:0062023
GeneOntologyCellularComponentcatenin complex

CDH20 CDH24 CDH7 CDH18

4.51e-04322374GO:0016342
GeneOntologyCellularComponentanchoring junction

KLHL24 IL16 ILK ITGA4 BMPR2 FAT1 CDH20 TJP2 DLG1 WNK3 CAP1 JCAD THEMIS DSG2 CNTNAP1 TGM2 CDH24 LLGL2 CSPG4 LRP1 PATJ CDH7 CDH18

7.63e-0497623723GO:0070161
DomainEGF_3

HGFAC ADAM23 LRP1B FAT1 ASTN2 C8A NOTCH3 FAT4 CNTNAP1 THBS3 SLIT3 LRP1 LTBP3

5.77e-0623522513PS50026
DomainCadherin_C

CDH20 DSG2 CDH24 CDH7 CDH18

1.06e-05252255PF01049
DomainCadherin_cytoplasmic-dom

CDH20 DSG2 CDH24 CDH7 CDH18

1.06e-05252255IPR000233
DomainEGF-like_dom

HGFAC ADAM23 LRP1B FAT1 FCGBP C8A NOTCH3 FAT4 CNTNAP1 THBS3 SLIT3 LRP1 LTBP3

1.08e-0524922513IPR000742
DomainCadherin

FREM1 FAT1 CDH20 FAT4 DSG2 CDH24 PCDH7 CDH7 CDH18

1.31e-051182259IPR002126
DomainEGF_1

HGFAC ADAM23 LRP1B FAT1 ASTN2 C8A NOTCH3 FAT4 CNTNAP1 THBS3 SLIT3 LRP1 LTBP3

1.39e-0525522513PS00022
DomainEGF_2

HGFAC ADAM23 LRP1B FAT1 ASTN2 C8A NOTCH3 FAT4 CNTNAP1 THBS3 SLIT3 LRP1 LTBP3

2.08e-0526522513PS01186
DomainEGF_Ca-bd_CS

LRP1B FAT1 NOTCH3 FAT4 THBS3 SLIT3 LRP1 LTBP3

2.25e-05972258IPR018097
DomainCatenin_binding_dom

CDH20 DSG2 CDH24 CDH7 CDH18

2.28e-05292255IPR027397
Domain-

CDH20 DSG2 CDH24 CDH7 CDH18

2.28e-052922554.10.900.10
DomainEGF_CA

LRP1B FAT1 NOTCH3 FAT4 THBS3 SLIT3 LRP1 LTBP3

2.62e-05992258PS01187
DomainEGF

HGFAC ADAM23 LRP1B FAT1 FCGBP NOTCH3 FAT4 CNTNAP1 THBS3 SLIT3 LRP1 LTBP3

2.94e-0523522512SM00181
DomainCadherin_CS

FAT1 CDH20 FAT4 DSG2 CDH24 PCDH7 CDH7 CDH18

5.24e-051092258IPR020894
DomainPI3K_Ras-bd_dom

PIK3C2A PIK3C2G PIK3CG

5.83e-0572253IPR000341
DomainPI3K_rbd

PIK3C2A PIK3C2G PIK3CG

5.83e-0572253SM00144
DomainPI3K_rbd

PIK3C2A PIK3C2G PIK3CG

5.83e-0572253PF00794
DomainPI3K_RBD

PIK3C2A PIK3C2G PIK3CG

5.83e-0572253PS51546
DomainCADHERIN_1

FAT1 CDH20 FAT4 DSG2 CDH24 PCDH7 CDH7 CDH18

6.77e-051132258PS00232
DomainCadherin

FAT1 CDH20 FAT4 DSG2 CDH24 PCDH7 CDH7 CDH18

6.77e-051132258PF00028
DomainLaminin_G

FAT1 FAT4 CNTNAP1 THBS3 CSPG4 SLIT3

6.86e-05582256IPR001791
DomainCADHERIN_2

FAT1 CDH20 FAT4 DSG2 CDH24 PCDH7 CDH7 CDH18

7.21e-051142258PS50268
Domain-

FAT1 CDH20 FAT4 DSG2 CDH24 PCDH7 CDH7 CDH18

7.21e-0511422582.60.40.60
DomainCA

FAT1 CDH20 FAT4 DSG2 CDH24 PCDH7 CDH7 CDH18

7.67e-051152258SM00112
DomainEGF_CA

LRP1B FAT1 NOTCH3 FAT4 THBS3 LRP1 LTBP3

8.04e-05862257PF07645
DomainEGF-like_CS

HGFAC ADAM23 LRP1B FAT1 C8A NOTCH3 FAT4 CNTNAP1 THBS3 SLIT3 LRP1 LTBP3

8.10e-0526122512IPR013032
DomainCadherin-like

FAT1 CDH20 FAT4 DSG2 CDH24 PCDH7 CDH7 CDH18

8.15e-051162258IPR015919
DomainLAM_G_DOMAIN

FAT1 FAT4 CNTNAP1 CSPG4 SLIT3

8.81e-05382255PS50025
DomainPI3K_C2

PIK3C2A PIK3C2G PIK3CG

9.24e-0582253SM00142
DomainPI3K_C2_dom

PIK3C2A PIK3C2G PIK3CG

9.24e-0582253IPR002420
DomainPI3K_C2

PIK3C2A PIK3C2G PIK3CG

9.24e-0582253PF00792
DomainPI3K_C2

PIK3C2A PIK3C2G PIK3CG

9.24e-0582253PS51547
DomainLaminin_G_2

FAT1 FAT4 CNTNAP1 CSPG4 SLIT3

1.13e-04402255PF02210
DomainEGF_CA

LRP1B FAT1 NOTCH3 FAT4 THBS3 SLIT3 LRP1 LTBP3

1.16e-041222258SM00179
DomainGrowth_fac_rcpt_

LRP1B FAT1 C8A NOTCH3 FAT4 THBS3 SLIT3 LRP1 LTBP3

1.17e-041562259IPR009030
DomainEGF-like_Ca-bd_dom

LRP1B FAT1 NOTCH3 FAT4 THBS3 SLIT3 LRP1 LTBP3

1.30e-041242258IPR001881
DomainPI3Ka

PIK3C2A PIK3C2G PIK3CG

1.37e-0492253PF00613
DomainLisH

TBL1Y TBL1X TBL1XR1

1.37e-0492253PF08513
DomainPI3Ka

PIK3C2A PIK3C2G PIK3CG

1.37e-0492253SM00145
Domain-

PIK3C2A PIK3C2G PIK3CG

1.37e-04922531.25.40.70
DomainDUF5050

LRP1B LRP1

1.44e-0422252IPR032485
DomainDUF5050

LRP1B LRP1

1.44e-0422252PF16472
DomainLamG

FAT1 FAT4 CNTNAP1 CSPG4 SLIT3

1.80e-04442255SM00282
DomainLRRNT

NTRK2 LRRC4B CPN2 LGR5 LHCGR LINGO1 SLIT3

1.83e-04982257IPR000372
DomainLRRNT

NTRK2 LRRC4B CPN2 LGR5 LHCGR LINGO1 SLIT3

1.83e-04982257SM00013
DomainPI_Kinase

PIK3C2A PIK3C2G PIK3CG

1.94e-04102253IPR015433
DomainNHL_repeat

NHLRC1 LRP1B TRIM2

1.94e-04102253IPR001258
DomainPInositide-3_kin_accessory_dom

PIK3C2A PIK3C2G PIK3CG

1.94e-04102253IPR001263
DomainNHL

NHLRC1 LRP1B TRIM2

1.94e-04102253PF01436
DomainPIK_HELICAL

PIK3C2A PIK3C2G PIK3CG

1.94e-04102253PS51545
DomainEGF-type_Asp/Asn_hydroxyl_site

LRP1B FAT1 NOTCH3 FAT4 SLIT3 LRP1 LTBP3

2.98e-041062257IPR000152
DomainKinase-like_dom

ILK NEK4 MYO3A BMPR2 COQ8A PIK3C2A PIK3C2G PIK3CG WNK3 KALRN NTRK2 SCYL3 CHD9 STK32C CHEK2 MACF1 WEE2

3.21e-0454222517IPR011009
DomainLisH

TBL1Y TBL1X TBL1XR1 SMU1

3.35e-04282254IPR006594
DomainLisH

TBL1Y TBL1X TBL1XR1 SMU1

3.35e-04282254SM00667
DomainLISH

TBL1Y TBL1X TBL1XR1 SMU1

3.35e-04282254PS50896
Domain-

MSH2 MSH3

4.30e-04322523.30.420.110
DomainDNA_mismatch_repair_MutS-lik_N

MSH2 MSH3

4.30e-0432252IPR007695
DomainMutS_I

MSH2 MSH3

4.30e-0432252PF01624
DomainLRRNT

NTRK2 LRRC4B CPN2 LGR5 SLIT3

4.35e-04532255PF01462
DomainZIP

SLC39A8 SLC39A13 SLC39A14

5.69e-04142253IPR003689
DomainZip

SLC39A8 SLC39A13 SLC39A14

5.69e-04142253PF02535
DomainPI3/4_kinase_CS

PIK3C2A PIK3C2G PIK3CG

7.05e-04152253IPR018936
DomainCys-rich_flank_reg_C

TLR8 NTRK2 LRRC4B CPN2 LINGO1 SLIT3

7.67e-04902256IPR000483
DomainLRRCT

TLR8 NTRK2 LRRC4B CPN2 LINGO1 SLIT3

7.67e-04902256SM00082
DomainEGF

HGFAC LRP1B FAT1 NOTCH3 CNTNAP1 SLIT3 LRP1

8.42e-041262257PF00008
DomainDNA_mmatch_repair_MutS_con_dom

MSH2 MSH3

8.53e-0442252IPR007860
DomainMutS_II

MSH2 MSH3

8.53e-0442252PF05188
Domain-

PIK3C2A PIK3C2G PIK3CG

8.60e-041622531.10.1070.11
DomainPI3Kc

PIK3C2A PIK3C2G PIK3CG

8.60e-04162253SM00146
Domain-

FAT1 FAT4 CNTNAP1 THBS3 CSPG4 SLIT3

1.02e-039522562.60.120.200
Domain-

CD300A PLXNB2 EBF2 ANOS1 MID1 ASTN2 CNTFR COL6A3 TRIM2 KALRN NTRK2 LRRC4B IGDCC4 TGM2 LINGO1 TREM2 TGM7 IL7R

1.16e-03663225182.60.40.10
Domain-

NHLRC1 LRP1B TRIM2 LRP1

1.21e-033922542.120.10.30
DomainPI3_PI4_kinase

PIK3C2A PIK3C2G PIK3CG

1.23e-03182253PF00454
DomainPI3_4_KINASE_1

PIK3C2A PIK3C2G PIK3CG

1.23e-03182253PS00915
DomainPI3_4_KINASE_2

PIK3C2A PIK3C2G PIK3CG

1.23e-03182253PS00916
DomainPI3/4_kinase_cat_dom

PIK3C2A PIK3C2G PIK3CG

1.23e-03182253IPR000403
DomainPI3_4_KINASE_3

PIK3C2A PIK3C2G PIK3CG

1.23e-03182253PS50290
DomainASX_HYDROXYL

LRP1B FAT1 NOTCH3 FAT4 LRP1 LTBP3

1.33e-031002256PS00010
DomainMUTSd

MSH2 MSH3

1.41e-0352252SM00533
DomainMUTSac

MSH2 MSH3

1.41e-0352252SM00534
DomainMutS_V

MSH2 MSH3

1.41e-0352252PF00488
DomainDNA_mismatch_repair_MutS_clamp

MSH2 MSH3

1.41e-0352252IPR007861
DomainDNA_MISMATCH_REPAIR_2

MSH2 MSH3

1.41e-0352252PS00486
DomainSpc97_Spc98

TUBGCP2 TUBGCP4

1.41e-0352252PF04130
DomainMutS_IV

MSH2 MSH3

1.41e-0352252PF05190
DomainMutS_III

MSH2 MSH3

1.41e-0352252PF05192
DomainDNA_mismatch_repair_MutS_C

MSH2 MSH3

1.41e-0352252IPR000432
DomainGCP

TUBGCP2 TUBGCP4

1.41e-0352252IPR007259
DomainDNA_mismatch_repair_MutS_core

MSH2 MSH3

1.41e-0352252IPR007696
DomainIg_E-set

A2M PLXNB2 EBF2 TRIM2 TGM2 TGM7

1.63e-031042256IPR014756
DomainGphrmn_rcpt_fam

LGR5 LHCGR

2.10e-0362252IPR002131
DomainDUF3398

DOCK11 DOCK6

2.10e-0362252PF11878
DomainDOCK_C/D_N

DOCK11 DOCK6

2.10e-0362252IPR021816
Domain6-blade_b-propeller_TolB-like

NHLRC1 LRP1B TRIM2 LRP1

2.25e-03462254IPR011042
DomainIg-like_fold

CD300A PLXNB2 EBF2 ANOS1 MID1 ASTN2 CNTFR COL6A3 TRIM2 KALRN NTRK2 LRRC4B IGDCC4 TGM2 LINGO1 TREM2 TGM7 IL7R

2.31e-0370622518IPR013783
DomainSpectrin

SPTBN1 KALRN MACF1

2.56e-03232253PF00435
DomainFN3

ANOS1 MID1 ASTN2 CNTFR COL6A3 KALRN IGDCC4 IL7R

2.90e-031992258PS50853
Pubmed

ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.

DPY19L3 B4GALNT1 C1RL PLXNB2 LRP1B SLC39A13 NEK4 BMPR2 FAT1 MGAT5 TMEM131L SCARA3 PIGO DSE NOTCH3 FAT4 DSG2 PIGK CNTNAP1 MADD TGM2 PPP2R2A THBS3 NDC1 PRCP CSPG4 LRP1 LTBP3 SLC39A14 R3HDM1 PCDH7 PLIN3 LRRFIP1

1.42e-1112012393335696571
Pubmed

Quantitation of HERV-K env gene expression and splicing in human breast cancer.

ERVK-6 ERVK-7 ERVK-21 ERVK-18 ERVK-19

1.47e-115239512629516
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

ILK ACACA DOCK11 SPTBN1 LUZP1 NEK4 FSIP2 BMPR2 PIK3C2A TJP2 BOD1L1 DOCK6 OBI1 WNK3 PML JCAD DSG2 CEP192 STK32C DENND4C MADD MACF1 R3HDM1 PATJ PCDH7 EDRF1

3.40e-108612392636931259
Pubmed

Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.

ERVK-6 ERVK-21 ERVK-9 ERVK-19 ERVK-8

1.12e-0812239514557543
Pubmed

A revised nomenclature for transcribed human endogenous retroviral loci.

ERVK-6 ERVK-7 ERVK-21 ERVK-9 ERVK-18 ERVK-19 ERVK-25 ERVK-24 ERVK-8

1.88e-0894239921542922
Pubmed

Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.

ERVK-21 ERVK-9 ERVK-18 ERVK-25 ERVK-24

1.17e-0718239518664271
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

ERCC6 ZNF184 FSIP2 SCML2 ABRAXAS1 ZBTB40 SGO2 BOD1L1 TAF2 PIGK POLH TOPBP1 CHD9 MSH2 MSH3 MORC2 TBL1XR1 RIF1

2.67e-076082391836089195
Pubmed

Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.

A2M ILK ACACA SPTBN1 C1RL PLXNB2 AGA PKM TMEM131L UQCRC2 PIGK TUSC3 CNTNAP1 TGM2 MTHFD1 PRCP LRP1 LTBP3

3.01e-076132391822268729
Pubmed

Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K.

ERVK-6 ERVK-18 ERVK-19

3.20e-073239310516026
Pubmed

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.

HAUS6 DPY19L3 TNFRSF10A BMPR2 FAT1 CLCN7 VPS13A DLG1 DOCK6 RAB5A OBI1 PIGO NOTCH3 CAP1 TUSC3 RIF1 SETD2 NDC1 MTHFD1 PDE4DIP MACF1 SLC39A14 ATP12A PLIN3

3.80e-0710612392433845483
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

ZBTB6 CTNNAL1 SPTBN1 PEX1 SCML2 BRD8 COQ8A AGA ZBTB40 TJP2 TMEM131L DLG1 BOD1L1 DSE PML CEP192 MADD CEP63 WDHD1 SLC17A9 MTHFD1 INTS13 MACF1 PATJ

5.57e-0710842392411544199
Pubmed

Functional proteomics mapping of a human signaling pathway.

A2M ZBTB6 ERCC6 SPTBN1 KANK1 USB1 MAN1C1 TUSC3 ANKRD13A TGM2 DKK1 CSPG4 PDE4DIP LRP1 MACF1 LTBP3 PLIN3

8.58e-075912391715231748
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

TUBGCP2 NEK4 SCML2 KANK1 MID1 TJP2 TMEM131L DLG1 BOD1L1 PIGK ICE1 DENND4C MADD TGM2 SETD2 WDHD1 PLPBP R3HDM1 PATJ

9.14e-077332391934672954
Pubmed

Comparative analysis of type II classic cadherin mRNA distribution patterns in the developing and adult mouse somatosensory cortex and hippocampus suggests significant functional redundancy.

CDH20 CDH24 CDH7 CDH18

1.03e-0612239422102170
Pubmed

Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.

ERVK-6 ERVK-7 ERVK-24

1.28e-064239310469592
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

HAUS6 ACACA LUZP1 SCML2 BRD8 PKM TJP2 DLG1 BOD1L1 TAF2 DSG2 SETD2 SMU1 PATJ PLIN3 LRRFIP1

1.53e-065492391638280479
Pubmed

Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.

A2M HGFAC SERPINA3 FCGBP C8A COL6A3 DSG2 NTRK2 CPN2 CSPG4 LRP1

1.90e-062572391116335952
Pubmed

Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.

ABCA13 LUZP1 MID1 VPS13A BOD1L1 DNHD1 CHD9 MSH2 MORC2 RP1

1.99e-062082391033230847
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

SERPINA3 ILK SPTBN1 PIK3C2A ADAMTS9 PKM ZBTB40 NOTCH3 COL6A3 AMPD1 ZFAT KALRN APPL2 PDE4DIP MACF1

2.14e-064972391523414517
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

HAUS6 ACACA MKS1 FAT1 VPS13A PKM TJP2 DLG1 FAT4 COPG1 DSG2 SCYL3 CEP192 RIF1 FRRS1 NDC1 MTHFD1 SLC39A14 PCDH7

2.15e-067772391935844135
Pubmed

The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.

SERPINA3 IL16 COL6A5 PLXNB2 FREM1 COL6A3 CPN2 TGM2 CSPG4

2.56e-06167239922159717
Pubmed

Differential Spatiotemporal Expression of Type I and Type II Cadherins Associated With the Segmentation of the Central Nervous System and Formation of Brain Nuclei in the Developing Mouse.

CDH20 CDH24 CDH7 CDH18

2.80e-0615239433833667
Pubmed

Pro-apoptotic function of checkpoint kinase-2 in syncytia elicited by the HIV-1 envelope.

PML TOPBP1 CHEK2

3.17e-065239319177012
Pubmed

Hepatic deficiency in transcriptional cofactor TBL1 promotes liver steatosis and hypertriglyceridemia.

TBL1Y TBL1X TBL1XR1

3.17e-065239321459324
Pubmed

Do checkpoint kinases contribute to HIV-1-mediated apoptosis?

PML TOPBP1 CHEK2

3.17e-065239319164952
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

GABRE TRPC4AP ACACA ZSWIM1 ITPK1 BMPR2 COQ8A DLG1 ASTN2 BOD1L1 DOCK6 SCARA3 NOTCH3 TBL1X MAN1C1 TUSC3 CHD9 CEP192 STK32C WDR37 TBL1XR1 PPP2R2A LRP1 MACF1 PATJ CATSPERG CPNE7

4.72e-0614892392728611215
Pubmed

Characterization of long cDNA clones from human adult spleen. II. The complete sequences of 81 cDNA clones.

TRPC4AP LUZP1 DNHD1 SLC17A9

4.82e-0617239412693554
Pubmed

Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity.

ERVK-6 ERVK-9 ERVK-19

6.31e-066239315063128
Pubmed

Structure of the MeCP2-TBLR1 complex reveals a molecular basis for Rett syndrome and related disorders.

TBL1Y TBL1X TBL1XR1

6.31e-066239328348241
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

CTNNAL1 ACACA ITGA4 PLXNB2 MID1 DLG1 DSG2 WDR37 LLGL2 NDC1 APPL2 MACF1 PCDH7

8.09e-064212391336976175
Pubmed

Large-scale proteomics and phosphoproteomics of urinary exosomes.

SERPINA3 ACY3 SPTBN1 FAT1 FCGBP PIK3C2A PKM ATP6V1C2 SLC5A12 CAP1 DNHD1 COL6A3 KALRN GRID1 TGM2 SLC12A1 APPL2 MTHFD1 PRCP TREH PATJ

8.39e-0610162392119056867
Pubmed

Report and abstracts of the Fourth International Workshop on Human Chromosome 2 Mapping 1996.

SPTBN1 ITGA4 COL6A3 XDH MSH2 LHCGR

9.75e-067123968751373
Pubmed

Zbtb7c is a molecular 'off' and 'on' switch of Mmp gene transcription.

TBL1Y TBL1X TBL1XR1

1.10e-057239327646874
Pubmed

The nuclear receptor corepressor deacetylase activating domain is essential for repression by thyroid hormone receptor.

TBL1Y TBL1X TBL1XR1

1.10e-057239315695367
Pubmed

Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.

DOCK11 TUBGCP2 LUZP1 NEK4 PIK3C2A TJP2 DOCK6 JCAD CEP192 DENND4C PPP2R2A R3HDM1 PATJ

1.49e-054462391324255178
Pubmed

HIV-1 Tat promotes Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3β signaling pathway.

PIK3C2A PIK3C2G PIK3CG CD34

1.74e-0523239423301033
Pubmed

A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma.

TBL1Y TBL1X TBL1XR1

1.75e-058239316127449
Pubmed

The LZT proteins; the LIV-1 subfamily of zinc transporters.

SLC39A8 SLC39A13 SLC39A14

1.75e-058239312659941
Pubmed

Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor.

TBL1Y TBL1X TBL1XR1

1.75e-058239323770565
Pubmed

Agonists of the TRAIL Death Receptor DR5 Sensitize Intestinal Stem Cells to Chemotherapy-Induced Cell Death and Trigger Gastrointestinal Toxicity.

TNFRSF10A LGR5 CHEK2

1.75e-058239326609054
Pubmed

Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.

ACACA ABCA13 FAT1 GLRX VPS13A ZBTB40 ERVK-25 USB1 KALRN NTRK2 STK32C PLEKHD1 PRCP PDE4DIP

3.25e-055522391410737800
Pubmed

Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.

IL16 ERCC6 ITGA4 TNFRSF10A PML MSH2 LIG4 LTA

3.60e-05179239819074885
Pubmed

Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells.

PIK3C2A PIK3C2G PIK3CG

3.71e-051023938798481
Pubmed

Expression of HIV-1 nef decreases basal phosphatidyl-inositol 3-kinase activity.

PIK3C2A PIK3C2G PIK3CG

3.71e-051023939247029
Pubmed

The HIV-1 nef protein interferes with phosphatidylinositol 3-kinase activation 1.

PIK3C2A PIK3C2G PIK3CG

3.71e-051023938636073
Pubmed

A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors.

TBL1Y TBL1X TBL1XR1

3.71e-0510239314980219
Pubmed

Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins.

ERVK-6 ERVK-21 ERVK-19

3.71e-0510239312970426
Pubmed

Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China.

ERCC6 POLH LIG4 LTA

3.91e-0528239419661089
Pubmed

E-cadherin interactome complexity and robustness resolved by quantitative proteomics.

SPTBN1 LUZP1 BMPR2 PKM TJP2 DLG1 NOTCH3 JCAD DSG2 DENND4C MACF1 PATJ PLIN3 LRRFIP1

4.18e-055652391425468996
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

ERCC6 PCNX3 TBL1Y LUZP1 SCML2 BRD8 PIK3C2A DLG1 UQCRC2 TAF2 DSG2 PIGK TOPBP1 ICE1 MORC2 TBL1XR1 RIF1 SETD2 APPL2 MTHFD1 INTS13 SMU1 MACF1 PATJ EDRF1

4.23e-0514972392531527615
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

HAUS6 ACACA DOCK11 LUZP1 SCML2 PIK3C2A TJP2 UQCRC2 TAF2 COPG1 MORC2 PPP2R2A MACF1 R3HDM1 PLIN3 LRRFIP1

4.69e-057242391636232890
Pubmed

ZIP14 and ZIP8 zinc/bicarbonate symporters in Xenopus oocytes: characterization of metal uptake and inhibition.

SLC39A8 SLC39A14

4.70e-052239223090441
Pubmed

Striking differences of LDL receptor-related protein 1B expression in mouse and human.

LRP1B LRP1

4.70e-052239215963947
Pubmed

Conformational trapping of mismatch recognition complex MSH2/MSH3 on repair-resistant DNA loops.

MSH2 MSH3

4.70e-052239221960445
Pubmed

PML colocalizes with and stabilizes the DNA damage response protein TopBP1.

PML TOPBP1

4.70e-052239212773567
Pubmed

Translational study of the whole transcriptome in rats and genetic polymorphisms in humans identifies LRP1B and VPS13A as key genes involved in tolerance to cocaine-induced motor disturbances.

LRP1B VPS13A

4.70e-052239233159041
Pubmed

DNA polymerase eta is the sole contributor of A/T modifications during immunoglobulin gene hypermutation in the mouse.

POLH MSH2

4.70e-052239217190840
Pubmed

X-linked late-onset sensorineural deafness caused by a deletion involving OA1 and a novel gene containing WD-40 repeats.

TBL1Y TBL1X

4.70e-052239210330347
Pubmed

Fusion of the tumor-suppressor gene CHEK2 and the gene for the regulatory subunit B of protein phosphatase 2 PPP2R2A in childhood teratoma.

PPP2R2A CHEK2

4.70e-052239216790090
Pubmed

Molecular cloning and sequencing of the murine alpha-2-macroglobulin receptor cDNA.

A2M LRP1

4.70e-05223928485155
Pubmed

The transglutaminase type 2 and pyruvate kinase isoenzyme M2 interplay in autophagy regulation.

PKM TGM2

4.70e-052239226702927
Pubmed

Mismatch recognition protein MutSbeta does not hijack (CAG)n hairpin repair in vitro.

MSH2 MSH3

4.70e-052239219525234
Pubmed

Involvement of cadherins 7 and 20 in mouse embryogenesis and melanocyte transformation.

CDH20 CDH7

4.70e-052239215273735
Pubmed

A Novel Tumor-Suppressor, CDH18, Inhibits Glioma Cell Invasiveness Via UQCRC2 and Correlates with the Prognosis of Glioma Patients.

UQCRC2 CDH18

4.70e-052239230078018
Pubmed

LINGO-1 receptor promotes neuronal apoptosis by inhibiting WNK3 kinase activity.

WNK3 LINGO1

4.70e-052239223482566
Pubmed

Promyelocytic leukemia activates Chk2 by mediating Chk2 autophosphorylation.

PML CHEK2

4.70e-052239216835227
Pubmed

Mechanism of mismatch recognition revealed by human MutSβ bound to unpaired DNA loops.

MSH2 MSH3

4.70e-052239222179786
Pubmed

hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA.

MSH2 MSH3

4.70e-05223928805365
Pubmed

(CAG)(n)-hairpin DNA binds to Msh2-Msh3 and changes properties of mismatch recognition.

MSH2 MSH3

4.70e-052239216025128
Pubmed

Biochemical characterization of human ZIP13 protein: a homo-dimerized zinc transporter involved in the spondylocheiro dysplastic Ehlers-Danlos syndrome.

SLC39A13 SLC39A14

4.70e-052239221917916
Pubmed

Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.

ERVK-6 ERVK-19

4.70e-05223929060628
Pubmed

Slc39a14 gene encodes ZIP14, a metal/bicarbonate symporter: similarities to the ZIP8 transporter.

SLC39A8 SLC39A14

4.70e-052239218270315
Pubmed

Alpha-1 antichymotrypsin and alpha-2 macroglobulin gene polymorphisms are not associated with Korean late-onset Alzheimer's disease.

A2M SERPINA3

4.70e-052239211290389
Pubmed

Critical role of spectrin in hearing development and deafness.

SPTBN1 ATOH1

4.70e-052239231001589
Pubmed

α-2-Macroglobulin induces the shedding of microvesicles from cutaneous wound myofibroblasts.

A2M LRP1

4.70e-052239230479021
Pubmed

Ethanol-induced formation of colorectal tumours and precursors in a mouse model of Lynch syndrome.

MSH2 LGR5

4.70e-052239234543445
Pubmed

Association study of the A2M and LRP1 Genes with Alzheimer disease in the Han Chinese.

A2M LRP1

4.70e-052239216040006
Pubmed

Transducin β-like 1, X-linked and nuclear receptor co-repressor cooperatively augment the ligand-independent stimulation of TRH and TSHβ gene promoters by thyroid hormone receptors.

TBL1Y TBL1X

4.70e-052239229794369
Pubmed

Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity.

ERVK-6 ERVK-18

4.70e-052239211672541
Pubmed

Tissue-Specific Induction of Mouse ZIP8 and ZIP14 Divalent Cation/Bicarbonate Symporters by, and Cytokine Response to, Inflammatory Signals.

SLC39A8 SLC39A14

4.70e-052239224728862
Pubmed

Nek4 regulates entry into replicative senescence and the response to DNA damage in human fibroblasts.

NEK4 CHEK2

4.70e-052239222851694
Pubmed

Modulation of M2-type pyruvate kinase activity by the cytoplasmic PML tumor suppressor protein.

PKM PML

4.70e-052239218298799
Pubmed

FAT1 and MSH2 Are Predictive Prognostic Markers for Chinese Osteosarcoma Patients Following Chemotherapeutic Treatment.

FAT1 MSH2

4.70e-052239235279875
Pubmed

Neuron/Glial Antigen 2-Type VI Collagen Interactions During Murine Temporomandibular Joint Osteoarthritis.

COL6A3 CSPG4

4.70e-052239230635602
Pubmed

Association of polymorphisms in the LRP1 and A2M genes with Alzheimer's disease in the northern Chinese Han population.

A2M LRP1

4.70e-052239223186781
Pubmed

TBL1X: At the crossroads of transcriptional and posttranscriptional regulation.

TBL1X TBL1XR1

4.70e-052239236206873
Pubmed

A role of chondroitin sulfate glycosaminoglycan binding site in alpha4beta1 integrin-mediated melanoma cell adhesion.

ITGA4 CSPG4

4.70e-05223929488735
Pubmed

Manganese Uptake by A549 Cells is Mediated by Both ZIP8 and ZIP14.

SLC39A8 SLC39A14

4.70e-052239231261654
Pubmed

Distinct binding sites in the structure of alpha 2-macroglobulin mediate the interaction with beta-amyloid peptide and growth factors.

A2M LRP1

4.70e-052239211823454
Pubmed

S-phase-specific activation of Cds1 kinase defines a subpathway of the checkpoint response in Schizosaccharomyces pombe.

ERCC6 CHEK2

4.70e-05223929450932
Pubmed

Association of low-risk MSH3 and MSH2 variant alleles with Lynch syndrome: probability of synergistic effects.

MSH2 MSH3

4.70e-052239221128252
Pubmed

Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha.

MSH2 MSH3

4.70e-05223929677427
Pubmed

Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome.

MSH2 LGR5

4.70e-052239225088490
Pubmed

Glutaredoxin 1 up-regulates deglutathionylation of α4 integrin and thereby restricts neutrophil mobilization from bone marrow.

ITGA4 GLRX

4.70e-052239230598505
Pubmed

PI3Kγ Activates Integrin α4 and Promotes Immune Suppressive Myeloid Cell Polarization during Tumor Progression.

ITGA4 PIK3CG

4.70e-052239228963139
Pubmed

NMR solution structure of complement-like repeat CR3 from the low density lipoprotein receptor-related protein. Evidence for specific binding to the receptor binding domain of human alpha(2)-macroglobulin.

A2M LRP1

4.70e-052239210652313
Pubmed

Multiple cadherin mRNA expression and developmental regulation of a novel cadherin in the developing mouse eye.

CDH24 CDH18

4.70e-052239210328938
Pubmed

Effective oligonucleotide-mediated gene disruption in ES cells lacking the mismatch repair protein MSH3.

MSH2 MSH3

4.70e-052239216437133
Pubmed

Alpha2-macroglobulin inhibits the malignant properties of astrocytoma cells by impeding beta-catenin signaling.

A2M LRP1

4.70e-052239220048078
Pubmed

Allograft TNFbeta and IL16 polymorphisms influence HCV recurrence and severity after liver transplantation.

IL16 LTA

4.70e-052239216447204
InteractionC2CD4B interactions

PLXNB2 LRP1B FAT1 FAT4 ICE1 SETD2 MACF1 PATJ PCDH7

1.25e-09442279int:C2CD4B
InteractionRHOF interactions

ILK DOCK11 SPTBN1 TUBGCP2 TNFRSF10A PLXNB2 BMPR2 FAT1 CLCN7 PIK3C2A VPS13A DLG1 UQCRC2 FAT4 COPG1 DSG2 PIGK KTI12 MSH3 DENND4C NDC1 MACF1 SLC39A14 PCDH7

6.77e-0767322724int:RHOF
InteractionFBXO2 interactions

ADAM23 C1RL ITGA4 PLXNB2 LRP1B FBXO2 AGA TMEM131L C8A SCARA3 NOTCH3 PIGK CNTNAP1 LINGO1 PRCP CSPG4 GALNT5

4.53e-0641122717int:FBXO2
InteractionKCNA3 interactions

HAUS6 IL16 CTNNAL1 ABCA13 SPTBN1 LUZP1 MID1 VPS13A PKM DLG1 BOD1L1 CAP1 DNHD1 DSG2 NTRK2 CHD9 MSH2 MORC2 DENND4C MTHFD1 MACF1 RP1 PATJ PCDH7 PLIN3

1.79e-0587122725int:KCNA3
InteractionBAG2 interactions

ILK PEX1 TUBGCP2 LUZP1 MKS1 NEK4 BRD8 PIK3C2A BOD1L1 TAF2 OBI1 WNK3 NOTCH3 TBL1X PML TBL1XR1 RPAP1 WDHD1 R3HDM1 EDRF1

2.70e-0562222720int:BAG2
InteractionCDH12 interactions

CDH24 CHEK2 CDH7 CDH18

3.33e-05172274int:CDH12
GeneFamilyCD molecules|Type II classical cadherins

CDH20 CDH24 CDH7 CDH18

3.78e-061315841186
GeneFamilyPhosphatidylinositol 3-kinase subunits

PIK3C2A PIK3C2G PIK3CG

3.55e-0581583831
GeneFamilyMembrane associated guanylate kinases|PDZ domain containing|Scribble complex

DLG1 LLGL2

4.50e-04415821224
GeneFamilyFibronectin type III domain containing

ANOS1 MID1 ASTN2 CNTFR KALRN IGDCC4 IL7R

5.20e-041601587555
GeneFamilyMutS homologs|PWWP domain containing

MSH2 MSH3

7.46e-04515821026
GeneFamilyWD repeat domain containing

TBL1Y TBL1X WDR37 TBL1XR1 PPP2R2A LLGL2 WDHD1 SMU1

2.17e-032621588362
GeneFamilyTransglutaminases

TGM2 TGM7

2.62e-0391582773
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

NEK4 FAT1 MGAT5 PIK3C2A MID1 VPS13A TJP2 TMEM131L DLG1 TBL1X TRIM2 TOPBP1 CHD9 MSH2 MSH3 WDR37 RIF1 PPP2R2A SETD2 DKK1 WDHD1 MACF1 R3HDM1 IL7R LRRFIP1

1.50e-0785622925M4500
CoexpressionBOQUEST_STEM_CELL_UP

SERPINA3 LRP1B ABCA8 FAT1 SCARA3 DSE COL6A3 MAN1C1 NTRK2 SLIT3 PDE4DIP LRP1 SLC39A14

5.64e-0726122913M1834
CoexpressionATF2_S_UP.V1_DN

A2M SERPINA3 ACACA C1RL ABCA8 SLC39A8 DENND4C SLIT3 PDE4DIP LTBP3 CATSPERG

8.41e-0718722911M2681
CoexpressionGSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN

B4GALNT1 CD300A COQ8A PIK3CG TMEM131L CHD9 MADD CEP63 PRCP PDE4DIP IL7R

1.63e-0620022911M8486
CoexpressionGSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_DN

SERPINA3 GARIN1B CNTFR CAP1 TBL1X THEMIS ANKRD13A WEE2 SLC39A14 IL7R

1.13e-0520022910M6550
CoexpressionDAZARD_RESPONSE_TO_UV_NHEK_DN

FAT1 KANK1 BRD8 VPS13A TMEM131L CHD9 ICE1 WDR37 RIF1 DKK1 WDHD1 EDRF1

1.45e-0530022912M8702
CoexpressionHEVNER_CORTEX_RADIAL_GLIA_PROGENITORS

TBL1Y FAT1 KLHL13 MID1 TJP2 SCARA3 NOTCH3 TBL1X CEP192 IGDCC4 WDHD1 SLC26A7 MTHFD1 CHEK2

2.98e-0543222914MM419
CoexpressionMTOR_UP.V1_DN

SLC39A13 COQ8A SCARA3 XDH KCNH3 THBS3 SLIT3 TREM2 EDRF1

3.39e-051822299M2670
CoexpressionDESCARTES_MAIN_FETAL_SMOOTH_MUSCLE_CELLS

EBF2 NOTCH3 COL6A3 CNTNAP1 CSPG4

4.48e-05452295M40098
CoexpressionHE_LIM_SUN_FETAL_LUNG_C0_PERICYTE

ITGA4 MYO3A ADAMTS9 DOCK6 NOTCH3 GPM6B LRRC4B LINGO1 CSPG4

5.79e-051952299M45684
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN

FAT1 MGAT5 MID1 VPS13A TJP2 TBL1X TRIM2 TOPBP1 CHD9 MSH2 PPP2R2A SETD2 R3HDM1 IL7R

6.73e-0546622914M13522
CoexpressionGSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP

AGA TJP2 TAF2 COL6A3 POLH TOPBP1 MTHFD1 LTA SLC39A14

6.77e-051992299M4607
CoexpressionGSE27786_CD4_VS_CD8_TCELL_DN

B4GALNT1 ACACA TUBGCP2 THEMIS TEX15 FRRS1 APPL2 SLC17A9 SMU1

6.77e-051992299M4821
CoexpressionRODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP

HAUS6 ZNF184 GLRX DLG1 SGO2 BOD1L1 DSE DSG2 POLH TUSC3 TOPBP1 TBL1XR1 CEP63 TGM2 LIG4 RIF1 NDC1 WDHD1

7.00e-0572122918M10237
CoexpressionGSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP

ACACA PKD1L2 LUZP1 NOVA2 PML COL6A3 PLCD4 TGM2 INTS13

7.04e-052002299M5979
CoexpressionGSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN

B4GALNT1 PIK3CG TMEM131L GPM6B USB1 CHD9 APPL2 PDE4DIP IL7R

7.04e-052002299M7150
CoexpressionGSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN

ACACA MID1 SCARA3 PIGO PML KCNH3 RPAP1 ZNF518B SLC39A14

7.04e-052002299M6201
CoexpressionGSE30083_SP2_VS_SP4_THYMOCYTE_DN

ITGA4 TJP2 DSE MAN1C1 XDH MADD APPL2 SLC17A9 PATJ

7.04e-052002299M5035
CoexpressionGSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP

CDKN2D TRPC4AP BRD8 TMEM131L SGO2 POLH MSH2 MSH3 ZNF518B

7.04e-052002299M8959
CoexpressionGSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP

ACACA DCSTAMP FBXO2 SLC5A12 CPN2 LGR5 MADD LHCGR RRH

7.04e-052002299M5003
CoexpressionCARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP

MGAT5 KCNU1 NOTCH3 COL6A3 LGR5 CD34 SLIT3 R3HDM1

9.36e-051622298M45037
CoexpressionRIGGI_EWING_SARCOMA_PROGENITOR_UP

A2M ITGA4 FREM1 SLC39A8 EBF2 KLHL13 JCAD FAT4 KALRN IGDCC4 LINGO1 LSM8 PCDH7

1.35e-0443722913M15981
ToppCell10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

A2M EBF2 FAT1 ADAMTS9 SCARA3 NOTCH3 COL6A3 NTRK2 CNTNAP1 LINGO1 CSPG4 SLIT3

3.27e-10189230121ff4f8da572bdc6356e9df9f41a7f62c81d4c570
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

SPTBN1 ABCA8 FREM1 LURAP1L COL6A3 KALRN TBL1XR1 SLIT3 LRP1 MACF1 UNC13C PCDH7

5.27e-101972301231a1852911bda38543916585fda34255fd62a134
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

SPTBN1 LRP1B ABCA8 FREM1 LURAP1L COL6A3 FAT4 TBL1XR1 SLIT3 MACF1 UNC13C PCDH7

5.27e-101972301211a4c417f035e554431a8f03be13b5eefa3530c0
ToppCellControl_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type

COL6A5 ABCA8 FREM1 CNTFR GPM6B COL6A3 TEX15 TGM2 SLIT3 CHEK2 LRP1 MACF1

6.27e-102002301264ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

COL6A5 ABCA8 FREM1 LURAP1L SCARA3 GPM6B COL6A3 TGM2 SLIT3 CHEK2 LRP1 MACF1

6.27e-1020023012b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

COL6A5 ABCA8 FREM1 LURAP1L SCARA3 GPM6B COL6A3 TGM2 SLIT3 CHEK2 LRP1 MACF1

6.27e-102002301250ca6550998e461ef26dd670351060bd940765a8
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type

COL6A5 ABCA8 FREM1 CNTFR GPM6B COL6A3 TEX15 TGM2 SLIT3 CHEK2 LRP1 MACF1

6.27e-1020023012a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

A2M ABCA13 PKD1L2 LRP1B FREM1 FAT1 PIK3C2G FAT4 KALRN GRID1 UNC13C

3.42e-09184230112cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

A2M ABCA13 PKD1L2 LRP1B FREM1 FAT1 PIK3C2G FAT4 KALRN GRID1 UNC13C

3.42e-09184230112b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

A2M ABCA13 PKD1L2 LRP1B FREM1 FAT1 PIK3C2G FAT4 KALRN GRID1 UNC13C

3.42e-0918423011ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FREM1 EBF2 PIK3C2G MID1 PKM ATP6V1C2 DSG2 TOP6BL ANKRD13A SLC26A7 PCDH7

5.33e-0919223011f7e7491426bbd6ed29a465b58bf67acb93dbb90a
ToppCellMesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor

ABCA8 KLHL13 MID1 COL6A3 FAT4 NTRK2 IGDCC4 SLC26A7 CD34 SLIT3 PCDH7

5.33e-0919223011a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

ABCA8 LURAP1L ADAMTS9 NOTCH3 COL6A3 FAT4 TRIM2 NTRK2 CNTNAP1 SLC26A7 SLIT3

5.63e-09193230116ef9007c9d18fb775d08fb20cdf954a28d54d7eb
ToppCell10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

ABCA8 LURAP1L ADAMTS9 NOTCH3 COL6A3 FAT4 TRIM2 NTRK2 CNTNAP1 SLC26A7 SLIT3

5.63e-0919323011e4ea7ce011a80b81b841c907719aa532bed39d2e
ToppCell10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

ABCA8 LURAP1L ADAMTS9 NOTCH3 COL6A3 FAT4 TRIM2 NTRK2 CNTNAP1 SLC26A7 SLIT3

5.63e-0919323011cf2461af78f65616ce40d552ee9452295e3895ed
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

SPTBN1 ABCA8 FREM1 LURAP1L COL6A3 FAT4 SLIT3 LRP1 MACF1 UNC13C PCDH7

6.27e-09195230111cdf5f296029ae424d9dba42e86a6d111e4896e6
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

ABCA8 FREM1 LURAP1L COL6A3 FAT4 KALRN SLIT3 LRP1 MACF1 UNC13C PCDH7

6.61e-09196230111450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCellASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

A2M CTNNAL1 LUZP1 BMPR2 ADAMTS9 DOCK6 NOVA2 JCAD FAT4 TGM2 CD34

6.61e-091962301114dd6956ef420b660be0baf52a66960e57d75d16
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

SPTBN1 LRP1B ABCA8 FREM1 LURAP1L COL6A3 TBL1XR1 SLIT3 MACF1 UNC13C PCDH7

6.97e-09197230110034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCellASK452-Endothelial-Endothelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

A2M CTNNAL1 SPTBN1 LUZP1 BMPR2 ADAMTS9 TJP2 JCAD TGM2 CD34 IL7R

7.35e-0919823011e282769f5fa1765bcce79a0ed9d761bf2e14b012
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type

COL6A5 FREM1 CNTFR GPM6B COL6A3 TEX15 TGM2 SLIT3 CHEK2 LRP1 MACF1

7.74e-0919923011c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9
ToppCell(5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

A2M SPTBN1 COL6A5 ABCA8 LURAP1L GPM6B COL6A3 TGM2 SLIT3 LRP1 MACF1

7.74e-0919923011b4a737575be9f8c65771832dd8cd25328d5dae0d
ToppCellLPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type

CTNNAL1 SPTBN1 LUZP1 BMPR2 PIK3C2A PML TGM2 PRCP CD34 MACF1 IL7R

8.16e-0920023011edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCellLPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CTNNAL1 SPTBN1 LUZP1 BMPR2 DOCK6 JCAD PRCP CD34 MACF1 ZNF518B IL7R

8.16e-09200230115c092b2ecc081b5d04476c56333c338cd89ab984
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

A2M IL16 COL6A5 ABCA8 FREM1 KLHL13 COL6A3 FAT4 GRID1 LGR5 LRP1

8.16e-092002301158b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCellLPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CTNNAL1 SPTBN1 LUZP1 BMPR2 DOCK6 JCAD PRCP CD34 MACF1 ZNF518B IL7R

8.16e-092002301172ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCellControl_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type

CTNNAL1 SPTBN1 ITGA4 LUZP1 BMPR2 DOCK6 JCAD PRCP CD34 ZNF518B IL7R

8.16e-0920023011e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

COL6A5 ABCA8 FREM1 LURAP1L GPM6B COL6A3 TGM2 SLIT3 CHEK2 LRP1 MACF1

8.16e-092002301144a68bacdb3d5bf563bd35952176995850933a81
ToppCellControl_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type

CTNNAL1 SPTBN1 ITGA4 LUZP1 BMPR2 DOCK6 JCAD PRCP CD34 ZNF518B IL7R

8.16e-09200230113372c488a39fe812fa94e4f0564594186fea3db5
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

COL6A5 ABCA8 FREM1 LURAP1L GPM6B COL6A3 TGM2 SLIT3 CHEK2 LRP1 MACF1

8.16e-0920023011dc61016c61729f69649cfb21f6264e685ce83dea
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type

COL6A5 ABCA8 FREM1 CNTFR GPM6B COL6A3 TEX15 TGM2 SLIT3 LRP1 MACF1

8.16e-0920023011bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCellAdult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor

A2M COL6A5 EBF2 NOTCH3 COL6A3 TTYH2 GRID1 LRRC4B CSPG4 SLIT3

2.46e-0817323010fd6653d6be9ca6ac36798590694efe03cb758c67
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

A2M BMPR2 SCARA3 NOTCH3 KALRN NTRK2 GRID1 LGR5 CSPG4 SLIT3

2.74e-0817523010316f2ea930437bf1243b1c0f45e6bd864112c6f2
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

A2M BMPR2 SCARA3 NOTCH3 KALRN NTRK2 GRID1 LGR5 CSPG4 SLIT3

2.74e-0817523010a9f08e1e4c2997dcdd3e5d92daac480da19100b8
ToppCell10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

EBF2 FAT1 DOCK6 SCARA3 NOTCH3 COL6A3 PLCD4 IGDCC4 CSPG4 PCDH7

3.40e-081792301098c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL6A5 ABCA8 FREM1 ASTN2 GPM6B GRID1 IGDCC4 SLIT3 LRP1 PCDH7

3.58e-081802301008ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCelltumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass

A2M EBF2 ADAMTS9 NOTCH3 COL6A3 CNTNAP1 GRID1 LRRC4B LINGO1 CSPG4

4.19e-0818323010a03dd563af9b15cb1f5de5732a229405a9f82d84
ToppCell10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

ABCA8 ADAMTS9 SCARA3 GPM6B COL6A3 NTRK2 IGDCC4 SLC26A7 SLIT3 UNC13C

5.14e-0818723010f1d0fc625e0e7881b3f290742fd7148d995eb71e
ToppCell10x3'2.3-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

ABCA8 ADAMTS9 SCARA3 GPM6B COL6A3 NTRK2 IGDCC4 SLC26A7 SLIT3 UNC13C

5.14e-081872301002e7246ef5ad41773d14426254e139b156d45c1d
ToppCell10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

ABCA8 ADAMTS9 SCARA3 GPM6B COL6A3 NTRK2 IGDCC4 SLC26A7 SLIT3 UNC13C

5.14e-081872301008c73d125e0638c9e9878165bba2442c266c8a48
ToppCellChildren_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

A2M CTNNAL1 SPTBN1 BMPR2 NOVA2 JCAD FAT4 NTRK2 TUSC3 CD34

5.40e-0818823010117dc80fa940e6aa1b0187a43fdde33f3fcb578f
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAM23 VPS13A DLG1 KALRN KCNH3 LINGO1 SLIT3 R3HDM1 PCDH7 CDH18

5.68e-0818923010a75226616340045b581d08429d2e123e041dee55
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

A2M IL16 ABCA8 FREM1 GPM6B COL6A3 FAT4 SLIT3 MACF1 PCDH7

6.27e-08191230106688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

ABCA8 FREM1 KLHL13 CNTFR COL6A3 FAT4 IGDCC4 CD34 SLIT3 PCDH7

6.58e-0819223010e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

IL16 ABCA8 FREM1 KLHL13 CNTFR COL6A3 FAT4 IGDCC4 CD34 SLIT3

6.91e-08193230109ab47b360bee1d4f1092c2269e58acebe9584021
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ABCA8 KLHL13 MID1 FAT4 NTRK2 IGDCC4 SLC26A7 CD34 SLIT3 PCDH7

7.25e-0819423010439d3f17c1f4736122b330e98add9292c7036a8e
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ABCA8 FREM1 COL6A3 FAT4 KALRN MAN1C1 TGM2 SLIT3 UNC13C PCDH7

7.25e-0819423010011e14d9ed1393275f892060e7708ffadcd0767f
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LRP1B LURAP1L FAT1 ADAMTS9 PIK3C2G MID1 PKM TOP6BL ANKRD13A PCDH7

7.25e-081942301046070fbb0ee0eb9e1801c43b73a15707471056dc
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LRP1B LURAP1L FAT1 ADAMTS9 PIK3C2G MID1 PKM TOP6BL ANKRD13A PCDH7

7.25e-0819423010abacb6a8d7a9003f2f6c2be0305507f1c1c50347
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

SPTBN1 FREM1 COL6A3 FAT4 KALRN TBL1XR1 SLIT3 MACF1 UNC13C PCDH7

7.61e-08195230100e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

LRP1B KANK1 KLHL13 ASTN2 GALNT14 TRIM2 LLGL2 SLC12A1 RP1 PATJ

7.61e-08195230106477e6e7be5bd8eb99119a12ae16334ccddecd43
ToppCellASK454-Endothelial-Endothelium|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq

A2M CTNNAL1 BMPR2 ADAMTS9 DOCK6 NOVA2 JCAD FAT4 TGM2 CD34

7.99e-08196230102b777a2026b56839112fd179f2db482c49f4594a
ToppCell10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ADAMTS9 SCARA3 NOTCH3 GPM6B COL6A3 NTRK2 TUSC3 SLC26A7 LRP1 UNC13C

8.38e-08197230105afddde4e2b5cd55abe11e9b9efae02dbdc3da3a
ToppCell10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ADAMTS9 SCARA3 NOTCH3 GPM6B COL6A3 NTRK2 TUSC3 SLC26A7 LRP1 UNC13C

8.38e-0819723010b9745e382baa2725dfcae060701fb53f6c8a31fa
ToppCell10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

ADAMTS9 SCARA3 NOTCH3 GPM6B COL6A3 NTRK2 TUSC3 SLC26A7 LRP1 UNC13C

8.38e-08197230101baffd087ca194a7355fefbb3bf67befb14fe2de
ToppCellwk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

EBF2 LURAP1L MYO3A ADAMTS9 NOTCH3 GPM6B COL6A3 LRRC4B LINGO1 CSPG4

8.38e-081972301044cd1ece3633a31e8c9b667cd3cbc2749c06f478
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type

COL6A5 BIRC7 ABCA8 FREM1 EBF2 PIGO GPM6B COL6A3 MACF1 UNC13C

8.78e-08198230100c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

A2M LURAP1L MYO3A ADAMTS9 NOTCH3 NTRK2 LINGO1 SLC26A7 CSPG4 SLIT3

8.78e-08198230103222d064b6ecab0caa450a59fc1dc79e26fc6fd5
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

ABCA8 FREM1 LURAP1L COL6A3 FAT4 KALRN SLIT3 LRP1 MACF1 PCDH7

8.78e-081982301017dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

A2M CTNNAL1 ADAM23 SPTBN1 BMPR2 PIK3C2A ADAMTS9 NOVA2 TGM2 PRCP

8.78e-0819823010fb70a649e4e2edb32967328c1085dc5999c29a33
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

COL6A5 ABCA8 FREM1 SCARA3 COL6A3 TTYH2 TGM2 SLIT3 LRP1 MACF1

9.21e-0819923010a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

EBF2 ANOS1 CNTFR COL6A3 FAT4 LRRC4B THBS3 CSPG4 LRP1 CDH18

9.21e-081992301095d95e9b7bd3933188998ae94986213eb0f1e5ea
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

COL6A5 LURAP1L SCARA3 CNTFR GPM6B COL6A3 TGM2 SLIT3 CHEK2 LRP1

9.21e-081992301038ed3bc7daa993d9edcf3e7834597ebb06dd24f8
ToppCellcellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

A2M CTNNAL1 ADAM23 SPTBN1 BMPR2 PIK3C2A ADAMTS9 TGM2 PRCP IL7R

9.21e-081992301068412bc39639edc4045437d62548f7101b9f1989
ToppCellASK452-Endothelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq

A2M CTNNAL1 SPTBN1 LUZP1 BMPR2 ADAMTS9 TJP2 JCAD TGM2 CD34

9.21e-08199230100bc97a9a78aaafd1554ae6a61356ed9ea4983fa5
ToppCell10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

EBF2 ANOS1 SCARA3 CNTFR COL6A3 LRRC4B THBS3 CSPG4 LRP1 CDH18

9.65e-0820023010747c61d4e0b746278ae1f45ca4cd556c6961c76a
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

SPTBN1 COL6A5 ABCA8 FREM1 GPM6B COL6A3 SLIT3 CHEK2 LRP1 MACF1

9.65e-08200230109b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCellControl_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type

CTNNAL1 SPTBN1 ITGA4 LUZP1 BMPR2 JCAD PRCP CD34 ZNF518B IL7R

9.65e-0820023010041a34080120c9f613373c20dcc366292f558040
ToppCellControl_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type

CTNNAL1 SPTBN1 BMPR2 DOCK6 PML FAT4 PRCP MACF1 ZNF518B IL7R

9.65e-08200230103b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCellLung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

A2M EBF2 LURAP1L NOTCH3 COL6A3 GRID1 LRRC4B LINGO1 CSPG4 SLIT3

9.65e-0820023010c46e06b4f22d3456e67bc62a9ac198e8041965ad
ToppCellLPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

CTNNAL1 SPTBN1 BMPR2 PIK3C2A DOCK6 FAT4 PRCP MACF1 ZNF518B IL7R

9.65e-0820023010dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCellLPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type

CTNNAL1 SPTBN1 LUZP1 BMPR2 ADAMTS9 PML TGM2 PRCP CD34 IL7R

9.65e-08200230106f531a418ff25b59a543800cf4bce7b72404ce08
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

A2M IL16 ABCA8 FREM1 GPM6B COL6A3 TGM2 SLIT3 LRP1 PCDH7

9.65e-0820023010e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

COL6A5 LURAP1L SCARA3 GPM6B COL6A3 TGM2 SLIT3 CHEK2 LRP1 MACF1

9.65e-08200230103bdba9612cd7c612b76aa9abecc4a6529aabfc1c
ToppCellParenchyma_COVID-19-Stromal-TX-Smooth_muscle-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

A2M EBF2 LURAP1L NOTCH3 COL6A3 GRID1 LRRC4B LINGO1 CSPG4 SLIT3

9.65e-082002301078e9a40153d7ba5d9ea6393a37d26fc5c0220867
ToppCellLung_Parenchyma-Severe-Endothelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CTNNAL1 ADAM23 SPTBN1 BMPR2 PIK3C2A ADAMTS9 DOCK6 NOVA2 TGM2 CD34

9.65e-0820023010d9d0ffa18e5b4647966e19ad9830cbba6120677e
ToppCell10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

EBF2 ANOS1 SCARA3 CNTFR COL6A3 LRRC4B THBS3 CSPG4 LRP1 CDH18

9.65e-0820023010de1d193f773f4e2927baa6fc38d29754b015c6e6
ToppCellLung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

A2M EBF2 LURAP1L NOTCH3 COL6A3 GRID1 LRRC4B LINGO1 CSPG4 SLIT3

9.65e-082002301043b76e382b38b9856c07557a75e5b1ce0cee1d9e
ToppCellLung_Parenchyma-Severe-Endothelial-Endothelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CTNNAL1 ADAM23 SPTBN1 BMPR2 PIK3C2A ADAMTS9 DOCK6 NOVA2 TGM2 CD34

9.65e-0820023010e9d5ba140cabae11c437012d519b85f5412dcc94
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

A2M CTNNAL1 ADAMTS9 NOVA2 GALNT14 JCAD BPIFC TUSC3 CD34

1.84e-071632309ba7d02db0f0e2f9916ec8db52c067c87b6917c23
ToppCell356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells)

ADAM23 CCDC168 ABCA8 MID1 CNTFR NOVA2 SH3TC2 NTRK2 SLIT3

2.15e-0716623097286a37b2827f3747469ffd0d76cbe81116db7ee
ToppCell356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells)

ADAM23 CCDC168 ABCA8 MID1 CNTFR NOVA2 SH3TC2 NTRK2 SLIT3

2.15e-0716623097c2eee0a4f45795a956acf936b85bdb35f1b1624
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

B4GALNT1 COL6A5 ABCA8 ASTN2 GPM6B GRID1 SLIT3 PCDH7

2.91e-071252308b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b
ToppCellFetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

B4GALNT1 ITGA4 MYO3A FAT1 ADAMTS9 KLHL13 NOTCH3 TGM2 SLIT3

3.21e-071742309015d3742d3d79a57413a333f00ef2d380a9848dd
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FREM1 EBF2 ATP6V1C2 DSG2 MAN1C1 TOP6BL LRRC9 SLC26A7 LONRF2

3.36e-07175230998947a226b5a2ac7091ff9d34243ea7736add973
ToppCell3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

A2M LURAP1L MYO3A ADAMTS9 DOCK6 NOTCH3 COL6A3 LINGO1 CSPG4

3.88e-071782309e5e4742e35c3d90f82b830d77bdbdc45828c7deb
ToppCell10x3'2.3-week_12-13-Myeloid_macrophage-stroma-erythroid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

LURAP1L ANOS1 ATP6V1C2 JCAD NTRK2 GRID1 LGR5 IGDCC4 SLIT3

4.07e-071792309c17ae394b855f01f8ca1765c416fd8b34a96e60b
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL6A5 ABCA8 FREM1 ASTN2 GPM6B GRID1 SLIT3 LRP1 PCDH7

4.27e-0718023099b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

COL6A5 ABCA8 FREM1 ASTN2 GPM6B GRID1 SLIT3 LRP1 PCDH7

4.47e-0718123099e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

A2M IL16 COL6A5 ABCA8 FREM1 LURAP1L COL6A3 SLIT3 PCDH7

4.47e-0718123099ede19228ba5c0668a9c06c915510b95585216ef
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

A2M SLC39A8 KANK1 SGO2 DOCK6 DSG2 LRRC9 FRRS1 PCDH7

4.90e-071832309b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9

DOCK11 ITGA4 ABCA8 FREM1 EBF2 PIK3CG FAT4 NTRK2 ZNF518B

5.13e-07184230967164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCellFetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

LURAP1L MYO3A CDH20 ADAMTS9 DOCK6 NOTCH3 TTYH2 GRID1 CSPG4

5.37e-071852309a7dba7db79275884b2a93d8a16f2e0c739e71370
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KANK1 MGAT5 ASTN2 TRIM2 NTRK2 SLC12A1 PDE4DIP UNC13C RP1

5.37e-07185230903f64a7132b13a01ba47187e0e15c13ac88f7cb2
ToppCellCOVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations)

EBF2 LURAP1L CDH20 ADAMTS9 NOTCH3 GRID1 LRRC4B CSPG4 SLIT3

5.37e-0718523094905adaeeffd353e089578e5ea614437dbe794e6
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ADAM23 VPS13A DLG1 KALRN KCNH3 LINGO1 SLIT3 R3HDM1 CDH18

5.62e-07186230984ba666237c18189d7e7556bd92dd953af733c00
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK11 ABCA13 SLC39A8 FAT1 KANK1 ADAMTS9 ASTN2 GALNT14 SH3TC2

5.62e-0718623095c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

A2M EBF2 ADAMTS9 NOTCH3 GPM6B COL6A3 NTRK2 SLIT3 UNC13C

5.62e-0718623090b2ce9b8a4382d583240647217ad5e2d3fa555c1
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ITGA4 LURAP1L MYO3A TMEM131L NOTCH3 GRID1 LRRC4B CSPG4 SLIT3

5.88e-071872309ec4b694487cc446999c7b27b119950a4f252c4b3
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ITGA4 LURAP1L MYO3A TMEM131L NOTCH3 GRID1 LRRC4B CSPG4 SLIT3

5.88e-071872309530e4e6d91b5c0d9aa4543caa2b734a1674c5788
Drugvinylidene chloride

SERPINA3 CTNNAL1 ABCA13 CD300A ACY3 FREM1 SLC39A8 LURAP1L FAT1 KANK1 COQ8A SGO2 ATP6V1C2 SLC5A12 C8A SLC38A3 DSE GALNT14 TOPBP1 XDH CEP192 ASB15 IGDCC4 TGM2 SLC12A1 WDHD1 SLC26A7 MTHFD1 CSPG4 TREM2 LRP1 LTBP3 PATJ PLIN3 LRRFIP1

2.35e-06147523135ctd:C029297
DrugNaproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A

KLHL24 SPTBN1 CLCN7 DLG1 ASTN2 POLH DENND4C RPAP1 EDRF1 PLIN3 LRRFIP1

4.30e-06191231111706_DN
DrugRanitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A

KLHL24 SPTBN1 PEX1 DLG1 TRIM2 NTRK2 POLH TUSC3 MACF1 PCDH7 EDRF1

5.51e-06196231115425_DN
Drugclozapine; Up 200; 10uM; MCF7; HT_HG-U133A

HGFAC ZBTB6 TRPC4AP SPTBN1 LUZP1 ASTN2 USB1 MAN1C1 RPAP1 PLPBP EDRF1

5.79e-06197231116947_UP
DrugNizatidine [76963-41-2]; Up 200; 12uM; MCF7; HT_HG-U133A

A2M ZBTB6 CLCN7 ADAMTS9 MID1 DSE PML NTRK2 MORC2 RRH PCDH7

6.07e-06198231115406_UP
DrugFlufenamic acid [530-78-9]; Down 200; 14.2uM; HL60; HG-U133A

KLHL24 IL16 ADAM23 PLXNB2 LUZP1 PIK3CG VPS13A MSH3 MACF1 LRRFIP1

3.21e-05195231101420_DN
Drug0179445-0000 [211246-22-9]; Down 200; 1uM; MCF7; HT_HG-U133A

B4GALNT1 ACACA TBL1Y CLCN7 COQ8A ZBTB40 PIGO PML USB1 TOP6BL

3.36e-05196231103633_DN
DrugIsopropamide iodide [71-81-8]; Up 200; 8.4uM; MCF7; HT_HG-U133A

A2M ERCC6 ADAM23 SPTBN1 CLCN7 PML TGM2 PDE4DIP R3HDM1 CPNE7

3.36e-05196231106781_UP
Drugxanthopterin

AMPD1 XDH LTA

3.50e-0572313CID000008397
DrugPrimidone [125-33-7]; Down 200; 18.4uM; HL60; HT_HG-U133A

MYO3A MID1 NTRK2 TUSC3 LGR5 LIG4 RIF1 CD34 PDE4DIP PATJ

3.50e-05197231103065_DN
DrugSTOCK1N-35874; Down 200; 14uM; PC3; HT_HG-U133A

CDKN2D SPTBN1 ZBTB40 TMEM131L NOTCH3 PML SH3TC2 FAT4 TRIM2 TOP6BL

3.50e-05197231106583_DN
Drug(+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; PC3; HT_HG-U133A

CLCN7 NOTCH3 PML JCAD SH3TC2 FAT4 TRIM2 PDE4DIP LRP1 CPNE7

3.50e-05197231106663_DN
DrugFlecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A

SPTBN1 BIRC7 LUZP1 FBXO2 CLCN7 PML AMPD1 NTRK2 MSH3 PCDH7

3.66e-05198231103843_DN
DrugFlutamide [13311-84-7]; Up 200; 14.4uM; PC3; HT_HG-U133A

KLHL24 TNFSF4 PIK3CG DOCK6 NOVA2 GPM6B CD34 CSPG4 LRP1 EDRF1

3.82e-05199231104539_UP
DrugPhenethicillin potassium salt [132-93-4]; Up 200; 10uM; MCF7; HT_HG-U133A

HGFAC ITPK1 TNFSF4 PML MAN1C1 NTRK2 CNTNAP1 TGM2 THBS3 CDH18

3.82e-05199231106105_UP
DrugTolmetin sodium salt dihydrate [64490-92-2]; Down 200; 12.6uM; PC3; HT_HG-U133A

PEX1 ASTN2 CNTFR PML GPM6B TRIM2 THBS3 PDE4DIP LRP1 EDRF1

3.98e-05200231104088_DN
DrugMeropenem [96036-03-2]; Up 200; 10.4uM; HL60; HT_HG-U133A

A2M SERPINA3 SPTBN1 FBXO2 BMPR2 JCAD USB1 RIF1 LRP1 CPNE7

3.98e-05200231106141_UP
DrugPralidoxime chloride [51-15-0]; Up 200; 23.2uM; PC3; HT_HG-U133A

ABCA8 VPS13A ZBTB40 CNTFR NOVA2 PML NTRK2 PDE4DIP PATJ CPNE7

3.98e-05200231106283_UP
Drugplatensimycin

COQ8A PIK3C2A PIK3C2G PIK3CG CNTFR CSPG4

4.29e-05632316CID006857724
Drugmono-(2-ethylhexyl)phthalate

IL16 ADAM23 PEX1 LURAP1L FAT1 FCGBP PIK3C2G ATP6V1C2 C8A SCARA3 ZFAT KALRN TTYH2 LGR5 LHCGR LLGL2 SLIT3 ATP12A LRRFIP1

4.58e-0565823119ctd:C016599
DiseaseColorectal Carcinoma

ERCC6 ACACA ABCA13 ABCA8 FAT1 VPS13A UQCRC2 PIGO AMPD1 KALRN GRID1 MSH2 STK32C LGR5 TGM2 RPAP1 INTS13 CHEK2 LRP1 LONRF2 CDH7 EDRF1

2.39e-0870222422C0009402
Diseasesensory system disease (implicated_via_orthology)

TBL1Y TBL1X TBL1XR1

4.32e-0732243DOID:0050155 (implicated_via_orthology)
DiseaseMalignant neoplasm of breast

ERCC6 BMPR2 CDH20 ABRAXAS1 ASTN2 BOD1L1 NOTCH3 PDZD4 KALRN POLH XDH PLEKHD1 LHCGR TGM2 RIF1 SETD2 THBS3 LLGL2 DKK1 CHEK2 MACF1 GALNT5 LRRFIP1

8.32e-06107422423C0006142
DiseaseConventional (Clear Cell) Renal Cell Carcinoma

BIRC7 LRP1B MYO3A WNK3 DNHD1 ASB15 TGM2 SETD2

1.84e-051482248C0279702
DiseasePR interval

PCNX3 SPTBN1 ZNF184 MYO3A BMPR2 FAT1 COQ8A ZBTB40 DLG1 ASTN2 KALRN TGM2 MACF1 PLIN3

2.87e-0549522414EFO_0004462
Diseasecolorectal cancer (is_implicated_in)

ERCC6 LRP1B FAT1 MSH2 LIG4 SETD2 CHEK2

4.01e-051212247DOID:9256 (is_implicated_in)
Diseasecongenital diaphragmatic hernia (implicated_via_orthology)

FREM1 SLIT3 LRP1

9.03e-05122243DOID:3827 (implicated_via_orthology)
Diseasesevere acute respiratory syndrome, COVID-19

ADAM23 LRP1B ANOS1 PIK3C2G TBL1X ATP8B3 COL6A3 NTRK2 PDE4DIP UNC13C LTBP3 PATJ

1.74e-0444722412EFO_0000694, MONDO_0100096
Diseaseepilepsy (implicated_via_orthology)

LRP1B KCNU1 KALRN SLC12A1 LRP1 UNC13C ATP12A

2.59e-041632247DOID:1826 (implicated_via_orthology)
DiseaseColorectal cancer, hereditary nonpolyposis, type 1

MSH2 MSH3 CHEK2

3.82e-04192243C2936783
Diseasecomparative body size at age 10, self-reported

ZNF184 LRP1B EBF2 ASTN2 SLC38A3 AMPD1 NTRK2 PLCD4 GRID1 PATJ PCDH7

3.97e-0442022411EFO_0009819
DiseaseSarcomatoid Renal Cell Carcinoma

BIRC7 LRP1B DNHD1 ASB15 TGM2 SETD2

4.49e-041282246C1266043
DiseaseChromophobe Renal Cell Carcinoma

BIRC7 LRP1B DNHD1 ASB15 TGM2 SETD2

4.49e-041282246C1266042
DiseaseCollecting Duct Carcinoma of the Kidney

BIRC7 LRP1B DNHD1 ASB15 TGM2 SETD2

4.49e-041282246C1266044
DiseasePapillary Renal Cell Carcinoma

BIRC7 LRP1B DNHD1 ASB15 TGM2 SETD2

4.49e-041282246C1306837
DiseaseRenal Cell Carcinoma

BIRC7 LRP1B DNHD1 ASB15 TGM2 SETD2

4.49e-041282246C0007134
DiseaseKyphosis deformity of spine

SLC39A13 LTBP3

5.65e-0452242C0022821
Diseasemarginal zone B-cell lymphoma, systemic lupus erythematosus

MGAT5 KALRN

5.65e-0452242EFO_1000630, MONDO_0007915
Diseasebody weight

KLHL24 DPY19L3 RGPD1 LRP1B EBF2 RTL3 ASTN2 ZFAT COPG1 NTRK2 GRID1 CEP192 LHCGR SETD2 LINGO1 SLIT3 RRH LTBP3 PATJ PCDH7 CDH7

6.63e-04126122421EFO_0004338
Diseaselung non-small cell carcinoma (is_implicated_in)

ERCC6 LRP1B FAT1 MSH2 MSH3 IL7R

6.95e-041392246DOID:3908 (is_implicated_in)
Diseaseuterine fibroid

EBF2 KANK1 THEMIS LINGO1 CHEK2 ATOH1 PCDH7

8.52e-041992247EFO_0000731
DiseaseRS-10-hydroxywarfarin measurement

PIK3CG DOCK6 KALRN LIG4 SLC26A7

9.23e-04982245EFO_0803330
DiseaseHereditary Nonpolyposis Colorectal Neoplasms

MSH2 MSH3 CHEK2

9.86e-04262243C0009405
Diseaseblood rubidium measurement

ABCA13 PAPPA-AS1 RIF1

9.86e-04262243EFO_0021529
Diseasecystatin C measurement

ITPK1 EBF2 BMPR2 PIK3C2A KALRN NDC1 RPAP1 CSPG4 LRP1 CPNE7

1.07e-0340222410EFO_0004617
Diseaseindole-3-propionate measurement

SLC38A3 SLIT3 UNC13C

1.10e-03272243EFO_0010501
DiseaseHereditary non-polyposis colorectal cancer syndrome

MSH2 MSH3 CHEK2

1.10e-03272243C1112155
DiseaseCommon Migraine

ASTN2 LRP1

1.17e-0372242C0338480
Diseaseperitonitis (biomarker_via_orthology)

A2M XDH

1.17e-0372242DOID:8283 (biomarker_via_orthology)
Diseasevascular cell adhesion protein 1 measurement

ITGA4 MGAT5

1.17e-0372242EFO_0020846
Diseaseglaucoma

LRP1B GPM6B KALRN CHEK2 LTBP3 LSM8

1.18e-031542246MONDO_0005041
DiseaseColorectal Neoplasms

ABCA13 ABCA8 FAT1 GRID1 MSH2 LGR5 CHEK2 CDH7

1.32e-032772248C0009404
DiseaseHereditary Nonpolyposis Colorectal Cancer

MSH2 MSH3 CHEK2

1.36e-03292243C1333990
Diseaseurate measurement

PCNX3 ZNF184 SLC39A8 BMPR2 MGAT5 COQ8A ATP8B3 XDH TOP6BL THBS3 SLC12A1 CSPG4 SMU1 LRP1 ZNF518B LSM8

1.42e-0389522416EFO_0004531
Diseasecarcinoma (implicated_via_orthology)

DLG1 RAB5A FAT4 LLGL2

1.44e-03642244DOID:305 (implicated_via_orthology)
DiseaseHeadache

TJP2 ASTN2 LRP1 MACF1

1.44e-03642244HP_0002315
DiseaseMalignant mesothelioma

ILK COPG1 TBL1XR1 SETD2 LTA

1.49e-031092245C0345967
Diseasesleep duration, circadian rhythm, excessive daytime sleepiness measurement, insomnia measurement

PIGK PATJ

1.56e-0382242EFO_0004354, EFO_0005271, EFO_0007875, EFO_0007876
Diseaselysosomal Pro-X carboxypeptidase measurement

PRCP RP1

1.56e-0382242EFO_0801777
Diseasediastolic blood pressure, self reported educational attainment

PIK3C2G SLIT3

1.56e-0382242EFO_0004784, EFO_0006336
Diseasefemale breast cancer (is_implicated_in)

POLH CHEK2

1.56e-0382242DOID:0050671 (is_implicated_in)
DiseaseOsteitis Deformans

DCSTAMP PML

1.99e-0392242C0029401
Diseaselifestyle measurement, systolic blood pressure

EBF2 KALRN

1.99e-0392242EFO_0006335, EFO_0010724
Diseasemean platelet volume

NHLRC1 HAUS6 PCNX3 DOCK11 SPTBN1 BRD8 TMEM131L DSE JCAD KALRN MAN1C1 CHD9 SETD2 CHEK2 CATSPERG LSM8 LRRFIP1

2.14e-03102022417EFO_0004584
Diseaseage at menopause

ACACA TUBGCP4 BMPR2 PIK3CG ABRAXAS1 BOD1L1 NPIPB2 RIF1

2.27e-033022248EFO_0004704
Diseasetotal blood protein measurement

HGFAC SERPINA3 TRPC4AP SLC39A8 TNFSF4 TMEM131L NPIPB2 SETD2 CD34 MACF1

2.41e-0344922410EFO_0004536
DiseaseBone Diseases

SLC39A13 LTBP3

2.48e-03102242C0005940
Diseasemyelodysplastic syndrome

TAF2 GRID1

2.48e-03102242EFO_0000198
Diseasecolon cancer (is_implicated_in)

LRP1B MSH2 IL7R

2.56e-03362243DOID:219 (is_implicated_in)
DiseaseMajor Depressive Disorder

KALRN NTRK2 XDH CD34 SLIT3 LRP1 CDH7

2.66e-032432247C1269683
Diseaseurinary bladder cancer (is_implicated_in)

TNFRSF10A XDH MSH2 CHEK2

2.71e-03762244DOID:11054 (is_implicated_in)
DiseaseProstatic Neoplasms

SERPINA3 IL16 TNFRSF10A LRP1B PML MSH3 TBL1XR1 PPP2R2A SETD2 APPL2 CHEK2 PATJ

2.79e-0361622412C0033578
DiseaseMalignant neoplasm of prostate

SERPINA3 IL16 TNFRSF10A LRP1B PML MSH3 TBL1XR1 PPP2R2A SETD2 APPL2 CHEK2 PATJ

2.79e-0361622412C0376358
DiseaseGlioblastoma

FAT1 NOTCH3 PML TGM2

3.11e-03792244C0017636
DiseaseSchizophrenia

ABCA13 AGA DLG1 ASTN2 WNK3 PML NTRK2 GRID1 TGM2 SLC26A7 MTHFD1 SLIT3 ERVK-8 LRP1 LTA

3.23e-0388322415C0036341
DiseaseHMG CoA reductase inhibitor use measurement

HGFAC BMPR2 DOCK6 DENND4C SETD2 RP1

3.31e-031892246EFO_0009932
Diseaseopen-angle glaucoma

MGAT5 GPM6B MADD CHEK2 LTBP3 LSM8

3.48e-031912246EFO_0004190
DiseaseAmelogenesis Imperfecta

PEX1 LTBP3

3.60e-03122242C0002452
Diseaserotator cuff tear, shoulder impingement syndrome

SLC39A8 ASTN2

3.60e-03122242EFO_1001178, EFO_1001250
DiseaseGiant Cell Glioblastoma

FAT1 NOTCH3 PML TGM2

3.88e-03842244C0334588
Diseasebody surface area

RGPD1 SLC39A13 LUZP1 ITPK1 ASTN2 ZFAT COPG1 GRID1 SLIT3 MACF1 LTBP3 PATJ

3.93e-0364322412EFO_0022196
Diseasepain

SLC39A8 ITPK1 ASTN2 MSH2 LRP1 MACF1

3.95e-031962246EFO_0003843
Diseasegout

FAT1 MGAT5 NTRK2 GRID1 THBS3 ZNF518B

3.95e-031962246EFO_0004274
DiseaseCharcot-Marie-Tooth disease

SH3TC2 CNTNAP1 MORC2

3.98e-03422243cv:C0007959
Diseaseoral microbiome measurement

ITPK1 APPL2 ATP12A

3.98e-03422243EFO_0801229
Diseaseprimary immunodeficiency disease (is_implicated_in)

TLR8 PIK3CG IL7R

3.98e-03422243DOID:612 (is_implicated_in)
Diseasemigraine disorder, Headache

ITPK1 TJP2 ASTN2 LRP1

4.22e-03862244HP_0002315, MONDO_0005277
Diseaseosteitis deformans

DCSTAMP PML

4.24e-03132242EFO_0004261
DiseaseMigraine Disorders

NOTCH3 LRP1

4.24e-03132242C0149931
Disease

TNFSF4 LTA

4.24e-03132242608446
DiseaseMyocardial infarction, susceptibility to

TNFSF4 LTA

4.24e-03132242cv:C1832662
DiseaseChildhood Medulloblastoma

SCML2 PIK3CG ATOH1

4.26e-03432243C0278510
DiseaseMelanotic medulloblastoma

SCML2 PIK3CG ATOH1

4.26e-03432243C1275668
DiseaseMedullomyoblastoma

SCML2 PIK3CG ATOH1

4.26e-03432243C0205833
DiseaseDesmoplastic Medulloblastoma

SCML2 PIK3CG ATOH1

4.26e-03432243C0751291
DiseaseAdult Medulloblastoma

SCML2 PIK3CG ATOH1

4.26e-03432243C0278876
Diseasecancer (implicated_via_orthology)

KANK1 DLG1 RAB5A NOTCH3 MSH2 LLGL2 MACF1

4.55e-032682247DOID:162 (implicated_via_orthology)
DiseaseDNA methylation

ABCA13 LRP1B FREM1 PIK3CG DNHD1 JCAD FAT4 ZFAT TUSC3 RRH PCDH7 CDH18

4.59e-0365622412GO_0006306
DiseaseManganese Poisoning

SLC39A8 SLC39A14

4.92e-03142242C0677050
Diseasemalignant pleural mesothelioma (is_marker_for)

SETD2 IL7R

4.92e-03142242DOID:7474 (is_marker_for)
Diseasecholesterol:total lipids ratio, low density lipoprotein cholesterol measurement

HGFAC SLC39A8 NOVA2 MADD MACF1

4.94e-031442245EFO_0004611, EFO_0020943
Diseasecortical thickness

A2M KLHL24 B4GALNT1 SPTBN1 SLC39A8 LUZP1 CDH20 ADAMTS9 ASTN2 MSH3 PPP2R2A THBS3 LRP1 MACF1 ATOH1 LSM8 PCDH7

5.13e-03111322417EFO_0004840
DiseaseReplication Error Phenotype

MSH3 SETD2

5.64e-03152242C1721098
DiseaseMicrosatellite Instability

MSH3 SETD2

5.64e-03152242C0920269
Diseasenon-dense area measurement, mammographic density measurement

RGPD1 KCNU1

5.64e-03152242EFO_0005941, EFO_0006504
Diseasetumor necrosis factor beta measurement

ZBTB40 LTA

5.64e-03152242EFO_0008308
Diseaseserum albumin measurement

HGFAC SERPINA3 ABCA8 SLC39A8 SLC39A13 ZFAT TRIM2 MADD MACF1 PCDH7 IL7R

5.84e-0359222411EFO_0004535
Diseasewaist-hip ratio

ADAM23 SLC39A8 EBF2 ADAMTS9 DLG1 ASTN2 DOCK6 PML JCAD ZFAT NTRK2 CEP192 ASB15 LHCGR CD34 LTBP3 PATJ LONRF2

6.00e-03122622418EFO_0004343
DiseaseSquamous cell carcinoma of esophagus

FAT1 NOTCH3 FAT4 LTA

6.01e-03952244C0279626
Diseasealcohol use disorder measurement

ZNF184 SLC39A8 SLC39A13 JCAD LSM8 IL7R

6.03e-032142246EFO_0009458
Diseaselung adenocarcinoma (is_implicated_in)

LRP1B MSH2 SETD2

6.15e-03492243DOID:3910 (is_implicated_in)
Diseaselongevity

KALRN TEX15 SLC12A1 LINGO1 MTHFD1 RP1 LRRFIP1

6.20e-032842247EFO_0004300
Disease4-acetamidobutanoate measurement

PLXNB2 OBI1

6.42e-03162242EFO_0021003
Diseasemigraine without aura, susceptibility to, 4

ASTN2 LRP1

6.42e-03162242MONDO_0011847
DiseaseMedulloblastoma

SCML2 PIK3CG ATOH1

6.51e-03502243C0025149
Diseaseeye morphology measurement

LUZP1 KANK1 ASTN2 SLC38A3 TGM2 RP1

6.58e-032182246EFO_0007858
DiseaseDementia

NOTCH3 TREM2

7.24e-03172242C0497327
Diseaseresponse to radiation, Urinary retention

LRP1B COL6A3

7.24e-03172242GO_0009314, HP_0000016

Protein segments in the cluster

PeptideGeneStartEntry
GALAFQHLNTDSDTE

ABRAXAS1

16

Q6UWZ7
QLSTEAVEQVAHGSQ

AMER3

776

Q8N944
TQSELGTAFQLHSQV

CATSPERG

781

Q6ZRH7
STFFGNVNESAVVRH

CNTNAP1

121

P78357
AGVALHSSVQSVNFV

ERVK-18

376

O42043
VAGVALHSSVQSVNF

ERVK-19

486

O71037
VAGVALHSSVQSVNF

ERVK-8

486

Q902F8
AGVALHSSVQSVNFV

ERVK-9

486

Q9UKH3
LTHNQLETVAEGTFA

CPN2

296

P22792
VHLAQASFQIEAFGS

ADAM23

146

O75077
GQAFDFVLDLHNTTA

ACY3

106

Q96HD9
LFHAQQDSTGEALVN

CSPG4

1631

Q6UVK1
GVSHSQDTSFLNELN

C8A

266

P07357
AEADIISTVEFNHSG

PPP2R2A

26

P63151
ESDDGFSIHNATLQS

BRD8

666

Q9H0E9
QTNTADTVRFSTEGH

B4GALNT1

231

Q00973
NLTETSEAEIHQSFQ

SERPINA3

106

P01011
NLSEIENVHGFVSHS

DLG1

141

Q12959
FELHAISGEITNTHQ

FAT4

1146

Q6V0I7
GFDVNTLLADHISQS

ASB15

331

Q8WXK1
SLFAQINQGESITHA

CAP1

256

Q01518
TTVNVDGHVLAVSDN

EBF2

216

Q9HAK2
GFDDLHTEQILNSSA

ABCA13

281

Q86UQ4
HSRFIIGSVSEDNSE

ACACA

16

Q13085
DFVHSVQETHSQLLG

BIRC7

161

Q96CA5
TVDSLDVHAGRQTFQ

AMPD1

356

P23109
QAIAHGVTTSLVNFF

ATP8B3

1081

O60423
VAFVVAFHNLSDSTN

DPY19L3

431

Q6ZPD9
FLSSQLVFDDHGQLS

DNHD1

556

Q96M86
QEGHTAVVSFLAAES

CDKN2D

116

P55273
EDHSGNGTFVNTELV

CHEK2

161

O96017
AFQAHTDGQASTREI

ERCC6

1436

Q03468
EDEFGSQVTHTLDSL

ASTN2

311

O75129
NATTDEHGLVQFSIN

A2M

396

P01023
TQGNIFSAEVHGLES

IGDCC4

901

Q8TDY8
AEVIVHSDFSASNGN

IGDCC4

1131

Q8TDY8
TDSTGIDLHEFLVNT

R3HDM1

146

Q15032
FSSVFDHQVSAIGSD

PAPPA-AS1

71

Q5QFB9
QNGDSLVHAAFVAES

UQCRC2

261

P22695
HEFQESTIGAAFLTQ

RAB5A

46

P20339
DGSVFSQTEHNIVAT

RRH

16

O14718
HSSSQVSLGFDQIVD

PIK3C2G

31

O75747
VNFIVSDSGAHVLNS

INTS13

76

Q9NVM9
DTIATRFDGTHSNFV

KCNH3

16

Q9ULD8
LTHLNGVFISEEEAT

LRRC9

816

Q6ZRR7
TVEHQFGAQGDLTTE

ANKRD13A

306

Q8IZ07
QDVFVGSVEELSAAH

DSG2

161

Q14126
FHIETDAQTNEGIVT

DSG2

321

Q14126
AIDHFTGAVSTSENL

FAT1

511

Q14517
ASFIVQDVNITGHFS

ANOS1

556

P23352
AVSEVLHSESSVFGQ

MSH3

596

P20585
SAIFQLTFCGSHEIQ

OR10H2

161

O60403
GTSDRESIFFNSHNV

ITPK1

221

Q13572
FEEVQSHAFNGTTLT

LHCGR

186

P22888
TLSSVNGNEIHTLDF

LRP1B

226

Q9NZR2
QTFVVHAGTDTNGDI

MADD

1441

Q8WXG6
SVIHDGQQTAFDFTS

LLGL2

316

Q6P1M3
ASGSFLHQLDQVTSQ

KTI12

266

Q96EK9
NSFLGFVVEQHLNSS

MGAT5

421

Q09328
GIHNFESIEDATNAA

EDRF1

886

Q3B7T1
TSLAVGIDFHAENDT

LRP1

1921

Q07954
QIFVADTSEDHSNQV

ATP12A

411

P54707
QAFEHSDVDGVVTST

JCAD

1171

Q9P266
LQHNTNIDVQTEFSG

DDX60L

111

Q5H9U9
FQSHINSVANDIVES

FSIP2

2531

Q5CZC0
LDRDEVGNSSHVSFQ

CDH24

541

Q86UP0
VIVDVLSDTASNHNG

CLCN7

646

P51798
EHENVLAEFSSGQVA

FBXO2

226

Q9UK22
SQHSVFGFNQVSELL

PCNX3

136

Q9H6A9
TVAAENNHTVAFLGT

PLXNB2

396

O15031
TTTEQLQFTIFAAHG

PIK3C2A

681

O00443
HVFVNESVSNATAID

PCDH7

836

O60245
QLVDSGTQTDITFEH

PDZD4

66

Q76G19
FATVVSGEAESNHEV

NEK4

291

P51957
GTQDIIHDSSFNISV

DCSTAMP

346

Q9H295
VTDGTNSAEFVLHVE

FREM1

866

Q5H8C1
IFHSSVQLADTSEAG

IL16

56

Q14005
TVVLQDFSAGHSSEL

KALRN

1651

O60229
LHTAVTADAQGVFQI

NOTCH3

1876

Q9UM47
FQTEFSQGILLSSSH

OBI1

646

Q5W0B1
ISSHTNIVFSNGELD

PRCP

416

P42785
DLEQVHQFTNTETAT

KANK1

676

Q14678
STLQQAQGFHSEIED

MACF1

2456

O94854
VQSFTVHGDSQQLDV

DSE

671

Q9UL01
VHGDSQQLDVFIATS

DSE

676

Q9UL01
SEAGTAFIQTQQLHA

PKM

6

P14618
QLTTLEESVFHSVGN

LINGO1

346

Q96FE5
AEHADTVQLVSGFEA

TUBGCP2

806

Q9BSJ2
AVTEHDVNVAFQQSA

TUBGCP4

386

Q9UGJ1
HQEAFVCQIVTTEGS

GABRE

401

P78334
EGANDFVVTFNTSHL

IL7R

141

P16871
EGSLQETNLHLSTAF

KCNU1

881

A8MYU2
EVLFSATANVHENLT

LONRF2

311

Q1L5Z9
QGTAEALNAVHSFIA

NOVA2

86

Q9UNW9
GESEALSQIFADLHQ

GARIN1B

251

Q96KD3
GTVAILEQHFSTNAS

GPM6B

61

Q13491
DSVSVVLGQHFFNRT

HGFAC

456

Q04756
VLGQHFFNRTTDVTQ

HGFAC

461

Q04756
VAGVALHSSVQSVNF

ERVK-7

1246

P63135
SFGSVAASHIEDQAE

PIGK

21

Q92643
ELTFEVAGLNATFSH

PKD1L2

481

Q7Z442
VAGLNATFSHEQVSF

PKD1L2

486

Q7Z442
TNSTTHEFLFGALAE

MORC2

21

Q9Y6X9
QGTTLTFLDSHCEVN

GALNT14

191

Q96FL9
THNNVCLSSVFVSED

SCYL3

121

Q8IZE3
NVENSGFRTNEEIHS

BOD1L1

2716

Q8NFC6
ATNIDVRQHSFSGET

ADAMTS9

776

Q9P2N4
DHVETNGFSSLEENL

CHD9

376

Q3L8U1
VETHQSEVAQSFSGE

ICE1

1576

Q9Y2F5
SNTHSSVVLQGFDQL

KLHL13

71

Q9P2N7
DFSSGSSHAENILQI

KLHL24

41

Q6TFL4
TEEISNHFVQNSQGL

BPIFC

306

Q8NFQ6
TEADIFHQALLEGNT

DOCK11

1386

Q5JSL3
FHQALLEGNTATEVS

DOCK11

1391

Q5JSL3
SSLVGTTQNFSEEHL

DOCK6

1511

Q96HP0
TCIHAEETFQVTGQQ

CTNNAL1

466

Q9UBT7
LGVSQQTIFSVFHND

LIG4

196

P49917
AGVALHSSVQSVNFV

ERVK-24

376

P61566
VAGVALHSSVQSVNF

ERVK-25

486

P61570
VAGVALHSSVQSVNF

ERVK-6

486

Q69384
AGVALHSSVQSVNFV

ERVK-7

376

P61567
NFTVTVANEHRGSQA

FCGBP

2111

Q9Y6R7
ENFTVTVANEHRGSQ

FCGBP

3311

Q9Y6R7
AENFTVTVANEHRGS

FCGBP

4511

Q9Y6R7
VFTIDDTTGDIHAIQ

CDH20

106

Q9HBT6
QGDLDSVLSQLNFTH

CEP63

326

Q96MT8
QILQSFTAVETEGHA

FRRS1

551

Q6ZNA5
AQNATGDVLTFLDSH

GALNT5

576

Q7Z7M9
ADIHFLIDGSSSIQE

COL6A5

441

A8TX70
IHFTVAIDFTASNGD

CPNE7

381

Q9UBL6
GLLEFVDITATNHTN

GLRX

41

P35754
ENFTSLHDIVGNLVS

COL6A3

201

P12111
ALGHNATAITFDEFT

CNTFR

186

P26992
LHEGTNFVVDQSQAV

ILK

281

Q13418
SVQLDALHFSTFEDS

ATOH1

286

Q92858
DETNLHTTNVAQSIG

BMPR2

636

Q13873
NQSVNVFLGHTAIDE

C1RL

296

Q9NZP8
FDFGTQSTTEKIHNL

COQ8A

576

Q8NI60
LENEGDQVIHTSSFI

DENND4C

1701

Q5VZ89
ANFELTSVTQFAAHQ

APPL2

556

Q8NEU8
SISSHEGYTQIIAND

CFAP126

31

Q5VTH2
AGVALHSFVQSVNFV

ERVK-21

486

P61565
QFSDSSLIEDSQALH

LURAP1L

201

Q8IV03
SQENILQGFSTSHKE

LUZP1

611

Q86V48
SHQTLTIQGESDFSL

LTBP3

466

Q9NS15
SFHLNVSGEASLFEV

MAN1C1

246

Q9NR34
SHERVFSSSQGVEQV

LSM8

41

O95777
NILDVQTTTGECHFE

ITGA4

841

P13612
FIQEENIDAHNTSVA

CEP192

531

Q8TEP8
FINEDLSTTASQALH

AGA

141

P20933
HQTSSTLESIDVQEF

CDH18

701

Q13634
LETTVSDFGQSHLTE

HAUS6

641

Q7Z4H7
AHSFINEAVETNLAS

GRID1

236

Q9ULK0
NQGEHLGTTEATEAF

COPG1

56

Q9Y678
VAGVALHSSVQSVNF

HERVK_113

486

Q902F9
HQTGFEQTTLETSLQ

CCDC168

1516

Q8NDH2
ASSIFIIDENTGDIH

CDH7

91

Q9ULB5
EETITESFGNDHSTL

DKK1

151

O94907
EIGTIFTNINATDNH

SCARA3

356

Q6AZY7
TIDNFTHGLAVAASF

SLC39A13

226

Q96H72
HNFSEQSRIGSSELQ

SLC39A14

101

Q15043
QLDAVVSFAHVSNGA

MSH2

601

P43246
DLQHVASVTDSFTGA

PEX1

1031

O43933
TSLNEDSTVHGFLVQ

MTHFD1

86

P11586
GILDFTEQDVASHQS

CD34

271

P28906
TASAVTFDHQGNVIV

NHLRC1

321

Q6VVB1
TFDHQGNVIVADTSG

NHLRC1

326

Q6VVB1
LHDGTLNFTNVTVQD

LRRC4B

416

Q9NT99
TSTGHSLEKEFTNQE

LRRFIP1

466

Q32MZ4
TGNHALQSLISSENF

LGR5

451

O75473
ELQSGNQTSVSHFIL

OR10G6

21

Q8NH81
VHGNIEDAVTAFESI

RGPD1

651

P0DJD0
LENHDTDIFNTVVNG

RP1

1471

P56715
FQEGLASSIQDELSH

RTL3

361

Q8N8U3
LANGVDLTSFVTHFE

ATP6V1C2

91

Q8NEY4
FNNTTGNFSHVEIVK

SLC38A3

246

Q99624
VANEESEHNQASIVF

TRPC4AP

341

Q8TEL6
FSISDVETIRNGHDS

PLCD4

61

Q9BRC7
ESHSVVQGSIQFTVD

TOP6BL

361

Q8N6T0
DSEVVVNSVFAAAGH

TMEM131L

121

A2VDJ0
GETHSAVVDFEALNV

RIF1

151

Q5UIP0
LDGSFNHTLQIEENS

TAF2

571

Q6P1X5
ALQEQDSAFGAVHAQ

PML

246

P29590
VEDLQATFSSIHSFQ

PLIN3

366

O60664
NLDVTNEFHTANLST

SGO2

561

Q562F6
ITFIDENVATHSAGI

SLCO6A1

251

Q86UG4
GNTFNSITLQDEIHD

RMDN2

46

Q96LZ7
FQVSVINENHESSAA

SLC12A1

21

Q13621
FGQAQRVDLSSTHED

SLC17A9

421

Q9BYT1
STVTGDQRQELVAFH

SH3TC2

1156

Q8TF17
GELTQFTESQLQSHF

POLH

276

Q9Y253
SADFQHAVEVGSTNV

PLPBP

226

O94903
FTFGIESHISQSNIN

TBL1XR1

26

Q9BZK7
HTTFEHDIQALGTQV

SPTBN1

1846

Q01082
DIHSSNAVESLVQLF

STK32C

296

Q86UX6
TGASIDDFIQSVEHQ

ABCA8

921

O94911
LFAVGATHSASIQEE

CD300A

156

Q9UGN4
LVGEDQDSVNLTVHF

NTRK2

271

Q16620
NTDLTVFVEANIQHG

PIK3CG

376

P48736
ETVNDGQFHSVELVT

SLIT3

1231

O75094
GSDFDVFAHITNNTA

TGM2

486

P21980
AFTFGIESHISQSNI

TBL1X

76

O60907
SSVSVGDQFLVHQSE

THEMIS

381

Q8N1K5
GDQFLVHQSETTEVL

THEMIS

386

Q8N1K5
HGSVTFEDVAIAFSQ

ZNF30

11

P17039
SDNFITHITNESFQG

TLR8

71

Q9NR97
AAFQLTQGDQLSTHT

LTA

171

P01374
GSSQAQFVAESHIIL

TUSC3

271

Q13454
HGAAQEALVFTSSIN

ZFAT

481

Q9P243
HFENGETSIVISDVL

TJP2

56

Q9UDY2
SELSNQFSIDTVGSH

VPS13A

2266

Q96RL7
LNVTTDNTSLDDFHV

TNFSF4

151

P23510
QQTSEHALFSCSVVD

UNC13C

1721

Q8NB66
LEGFSQQSSIHNVLE

MKS1

516

Q9NXB0
VDSIESFVADINSGH

SMU1

41

Q2TAY7
RGHSSFVNEATFTQD

SMU1

346

Q2TAY7
HGNILLAAESEFEQT

PLEKHD1

111

A6NEE1
EVITASFDGETHSIQ

SCML2

421

Q9UQR0
LEVSGVDLQNASHSE

PATJ

1126

Q8NI35
DDANHTFSGIDALVS

TTYH2

126

Q9BSA4
TRFTTNANHVVFNGD

WDHD1

91

O75717
HCATNESVESITAFQ

MID1

41

O15344
THTNDTAFLQENIET

TREH

236

O43280
AFGVASHEDTLLQAS

ZBED8

81

Q8IZ13
TVVALEVDHFSNVGN

XDH

856

P47989
AVAVAHVNSFIFSQD

RPAP1

1306

Q9BWH6
FTFGIESHISQSNIN

TBL1Y

26

Q9BQ87
FQGDESIHSAVTNAL

THBS3

206

P49746
TSGHAQFLDLVSEVD

USB1

176

Q9BQ65
FVTELSGAHNTTVFQ

TREM2

11

Q9NZC2
HNEILSNADSLSTFV

TNFRSF10A

296

O00220
IFQSENGHDVSTDVQ

NPIPB2

71

A6NJ64
VAQSDGVVHQDSSVA

SETD2

2241

Q9BYW2
NVFQGHTDTVTSAVF

WDR37

361

Q9Y2I8
DVSVFDLHQQSHSGE

ZNF221

181

Q9UK13
FIDAGSNFASHAIVE

PIGO

146

Q8TEQ8
TAEEIFSLHGFSNAT

SLC39A8

76

Q9C0K1
TFTELSNENSALHEV

WEE2

246

P0C1S8
IDLTVSSDHFSGQQE

TEX15

2416

Q9BXT5
QSLEVTTHILSQFFG

ZSWIM1

256

Q9BR11
NFTAQALNHGTETEV

TRIM2

256

Q9C040
NQEFLAHGLSNIVSS

SLC26A7

341

Q8TE54
QSTNGSRLHIFDFDV

SLC5A12

216

Q1EHB4
FQSQNDHITFVAETG

TGM7

51

Q96PF1
EITNGINLNSDTAEH

TOPBP1

751

Q92547
HNLLSSASFQEAVTF

ZNF184

16

Q99676
GELFTSQAQLDSHLE

ZBTB40

1141

Q9NUA8
SVHNNGKSFINSETI

ZNF518B

446

Q9C0D4
HVESISTAGVENGQF

ZBTB6

221

Q15916
TSFGIEHISVFSETN

WNK3

1351

Q9BYP7
NVGNIEFSSVATEHQ

MYO3A

606

Q8NEV4
LGATFTVDAHQLDNQ

PDE4DIP

1181

Q5VU43
TTTFGEHLNAVQASA

NDC1

646

Q9BTX1